{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "epidrugs", "epigenetic", "histone deacetylases", "natural compounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35458763", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "15"}], "Language": ["eng"], "ELocationID": ["2568", "10.3390/molecules27082568"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "8", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "15"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.", "Abstract": {"AbstractText": ["Cancer is a complex pathology that causes a large number of deaths worldwide. Several risk factors are involved in tumor transformation, including epigenetic factors. These factors are a set of changes that do not affect the DNA sequence, while modifying the gene's expression. Histone modification is an essential mark in maintaining cellular memory and, therefore, loss of this mark can lead to tumor transformation. As these epigenetic changes are reversible, the use of molecules that can restore the functions of the enzymes responsible for the changes is therapeutically necessary. Natural molecules, mainly those isolated from medicinal plants, have demonstrated significant inhibitory properties against enzymes related to histone modifications, particularly histone deacetylases (HDACs). Flavonoids, terpenoids, phenolic acids, and alkaloids exert significant inhibitory effects against HDAC and exhibit promising epi-drug properties. This suggests that epi-drugs against HDAC could prevent and treat various human cancers. Accordingly, the present study aimed to evaluate the pharmacodynamic action of different natural compounds extracted from medicinal plants against the enzymatic activity of HDAC."]}, "AuthorList": [{"Identifier": ["0000-0001-9317-1631"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco."}], "LastName": "Bouyahya", "ForeName": "Abdelhakim", "Initials": "A"}, {"Identifier": ["0000-0003-0768-5914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbial Biotechnology and Bioactive Molecules Laboratory, Sciences and Technologies Faculty, Sidi Mohmed Ben Abdellah University, Imouzzer Road Fez, Fez B.P. 1796, Morocco."}], "LastName": "El Hachlafi", "ForeName": "Naoufal", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biotechnology Laboratory, Rabat Medical & Pharmacy School, Mohammed V University in Rabat, Rabat B.P. 6203, Morocco."}], "LastName": "Aanniz", "ForeName": "Tarik", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco."}], "LastName": "Bourais", "ForeName": "Ilhame", "Initials": "I"}, {"Identifier": ["0000-0003-4571-9089"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biotechnology, Environment, Agri-Food and Health (LBEAS), Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez B.P. 1796, Morocco."}], "LastName": "Mechchate", "ForeName": "Hamza", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environment and Health Team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Sidi Bouzid B.P. 4162, Morocco."}], "LastName": "Benali", "ForeName": "Taoufiq", "Initials": "T"}, {"Identifier": ["0000-0001-9376-5771"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Scientific Research, K. G. Razumovsky Moscow State University of Technologies and Management (The First Cossack University), 73 Zemlyanoy Val, 109004 Moscow, Russia."}], "LastName": "Shariati", "ForeName": "Mohammad Ali", "Initials": "MA"}, {"Identifier": ["0000-0001-7515-5670"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Biotechnology of Animal Reproduction, South Ural State Agrarian University, 13 Gagarin St., 457100 Troitsk, Russia."}], "LastName": "Burkov", "ForeName": "Pavel", "Initials": "P"}, {"Identifier": ["0000-0002-7725-9294"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro Tecnol\u00f3gico de la Carne de Galicia, R\u00faa Galicia No.4, Parque Tecnol\u00f3gico de Galicia, 32900 San Cibrao das Vi\u00f1as, Spain."}, {"Identifier": [], "Affiliation": "\u00c1rea de Tecnolox\u00eda dos Alimentos, Facultade de Ciencias, Universidade de Vigo, 32004 Ourense, Spain."}], "LastName": "Lorenzo", "ForeName": "Jos\u00e9 M", "Initials": "JM"}, {"Identifier": ["0000-0002-2730-7788"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand."}], "LastName": "Wilairatana", "ForeName": "Polrat", "Initials": "P"}, {"Identifier": ["0000-0002-9782-0835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, The University of Jordan, Amman 11942, Jordan."}], "LastName": "Mubarak", "ForeName": "Mohammad S", "Initials": "MS"}, {"Identifier": ["0000-0002-0308-1155"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Histology, Embryology, and Cytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat 10100, Morocco."}], "LastName": "El Omari", "ForeName": "Nasreddine", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Histone Deacetylase Inhibitors"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "Histone Deacetylases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Epigenesis, Genetic"}, {"QualifierName": [], "DescriptorName": "Epigenomics"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Histone Deacetylase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Histone Deacetylases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Processing, Post-Translational"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mansoori B., Mohammadi A., Davudian S., Shirjang S., Baradaran B. The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Adv. Pharm. Bull. 2017;7:339\u2013348. doi: 10.15171/apb.2017.041.", "ArticleIdList": ["10.15171/apb.2017.041", "PMC5651054", "29071215"]}, {"Citation": "Bouyahya A., El Menyiy N., Oumeslakht L., El Allam A., Balahbib A., Rauf A., Muhammad N., Kuznetsova E., Derkho M., Thiruvengadam M., et al. Preclinical and Clinical Antioxidant Effects of Natural Compounds against Oxidative Stress-Induced Epigenetic Instability in Tumor Cells. Antioxidants. 2021;10:1553. doi: 10.3390/antiox10101553.", "ArticleIdList": ["10.3390/antiox10101553", "PMC8533336", "34679688"]}, {"Citation": "Mann B.S., Johnson J.R., Cohen M.H., Justice R., Pazdur R. FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma. Oncologist. 2007;12:1247\u20131252. doi: 10.1634/theoncologist.12-10-1247.", "ArticleIdList": ["10.1634/theoncologist.12-10-1247", "17962618"]}, {"Citation": "Lee J., Huang S. Cancer Epigenetics: Mechanisms and Crosstalk of a HDAC Inhibitor, Vorinostat. Chemotherapy. 2013;2:14934. doi: 10.4172/2167-7700.1000111.", "ArticleIdList": ["10.4172/2167-7700.1000111", "PMC4169261", "25243102"]}, {"Citation": "Richon V.M. Cancer Biology: Mechanism of Antitumour Action of Vorinostat (Suberoylanilide Hydroxamic Acid), a Novel Histone Deacetylase Inhibitor. Br. J. Cancer. 2006;95:S2\u2013S6. doi: 10.1038/sj.bjc.6603463.", "ArticleIdList": ["10.1038/sj.bjc.6603463"]}, {"Citation": "Coiffier B., Pro B., Prince H.M., Foss F., Sokol L., Greenwood M., Caballero D., Borchmann P., Morschhauser F., Wilhelm M., et al. Results from a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma after Prior Systemic Therapy. J. Clin. Oncol. 2012;30:631\u2013636. doi: 10.1200/JCO.2011.37.4223.", "ArticleIdList": ["10.1200/JCO.2011.37.4223", "22271479"]}, {"Citation": "Patra S., Praharaj P.P., Klionsky D.J., Bhutia S.K. Vorinostat in Autophagic Cell Death: A Critical Insight into Autophagy-Mediated, -Associated and -Dependent Cell Death for Cancer Prevention. Drug Discov. Today. 2022;27:269\u2013279. doi: 10.1016/j.drudis.2021.08.004.", "ArticleIdList": ["10.1016/j.drudis.2021.08.004", "PMC8714665", "34400351"]}, {"Citation": "Lee H.-Z., Kwitkowski V.E., Del Valle P.L., Ricci M.S., Saber H., Habtemariam B.A., Bullock J., Bloomquist E., Li Shen Y., Chen X.-H., et al. FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma. Clin. Cancer Res. 2015;21:2666\u20132670. doi: 10.1158/1078-0432.CCR-14-3119.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-3119", "25802282"]}, {"Citation": "Oki Y., Buglio D., Fanale M., Fayad L., Copeland A., Romaguera J., Kwak L.W., Pro B., de Castro Faria S., Neelapu S., et al. Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma. Clin. Cancer Res. 2013;19:6882\u20136890. doi: 10.1158/1078-0432.CCR-13-1906.", "ArticleIdList": ["10.1158/1078-0432.CCR-13-1906", "PMC4409814", "24097867"]}, {"Citation": "Peng X., Sun Z., Kuang P., Chen J. Recent Progress on HDAC Inhibitors with Dual Targeting Capabilities for Cancer Treatment. Eur. J. Med. Chem. 2020;208:112831. doi: 10.1016/j.ejmech.2020.112831.", "ArticleIdList": ["10.1016/j.ejmech.2020.112831", "32961382"]}, {"Citation": "Bouyahya A., El Omari N., Hakkur M., El Hachlafi N., Charfi S., Balahbib A., Guaouguaou F.-E., Rebezov M., Maksimiuk N., Shariati M.A., et al. Sources, Health Benefits, and Biological Properties of Zeaxanthin. Trends Food Sci. Technol. 2021;118:519\u2013538. doi: 10.1016/j.tifs.2021.10.017.", "ArticleIdList": ["10.1016/j.tifs.2021.10.017"]}, {"Citation": "Balahbib A., El Omari N., Hachlafi N.E., Lakhdar F., El Menyiy N., Salhi N., Mrabti H.N., Bakrim S., Zengin G., Bouyahya A. Health Beneficial and Pharmacological Properties of P-Cymene. Food Chem. Toxicol. 2021;153:112259. doi: 10.1016/j.fct.2021.112259.", "ArticleIdList": ["10.1016/j.fct.2021.112259", "33984423"]}, {"Citation": "El Hachlafi N., Lakhdar F., Khouchlaa A., Bakrim S., El Omari N., Balahbib A., Shariati M.A., Zengin G., Fikri-Benbrahim K., Orlando G., et al. Health Benefits and Pharmacological Properties of Hinokitiol. Processes. 2021;9:1680. doi: 10.3390/pr9091680.", "ArticleIdList": ["10.3390/pr9091680"]}, {"Citation": "El Omari N., El Menyiy N., Zengin G., Goh B.H., Gallo M., Montesano D., Naviglio D., Bouyahya A. Anticancer and Anti-Inflammatory Effects of Tomentosin: Cellular and Molecular Mechanisms. Separations. 2021;8:207. doi: 10.3390/separations8110207.", "ArticleIdList": ["10.3390/separations8110207"]}, {"Citation": "El Omari N., Bakrim S., Bakha M., Lorenzo J.M., Rebezov M., Shariati M.A., Aboulaghras S., Balahbib A., Khayrullin M., Bouyahya A. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates. Nutrients. 2021;13:3714. doi: 10.3390/nu13113714.", "ArticleIdList": ["10.3390/nu13113714", "PMC8621755", "34835969"]}, {"Citation": "El Omari N., Bakha M., Imtara H., Guaouguaoua F.-E., Balahbib A., Zengin G., Bouyahya A. Anticancer Mechanisms of Phytochemical Compounds: Focusing on Epigenetic Targets. Environ. Sci. Pollut. Res. 2021;28:47869\u201347903. doi: 10.1007/s11356-021-15594-8.", "ArticleIdList": ["10.1007/s11356-021-15594-8", "34308524"]}, {"Citation": "Baylin S.B., Jones P.A. A Decade of Exploring the Cancer Epigenome\u2014Biological and Translational Implications. Nat. Rev. Cancer. 2011;11:726\u2013734. doi: 10.1038/nrc3130.", "ArticleIdList": ["10.1038/nrc3130", "PMC3307543", "21941284"]}, {"Citation": "Sandoval J., Esteller M. Cancer Epigenomics: Beyond Genomics. Curr. Opin. Genet. Dev. 2012;22:50\u201355. doi: 10.1016/j.gde.2012.02.008.", "ArticleIdList": ["10.1016/j.gde.2012.02.008", "22402447"]}, {"Citation": "Jones P.A., Baylin S.B. The Epigenomics of Cancer. Cell. 2007;128:683\u2013692. doi: 10.1016/j.cell.2007.01.029.", "ArticleIdList": ["10.1016/j.cell.2007.01.029", "PMC3894624", "17320506"]}, {"Citation": "Kanwal R., Gupta S. Epigenetics and Cancer. J. Appl. Physiol. 2010;109:598\u2013605. doi: 10.1152/japplphysiol.00066.2010.", "ArticleIdList": ["10.1152/japplphysiol.00066.2010", "PMC2928601", "20203073"]}, {"Citation": "You J.S., Jones P.A. Cancer Genetics and Epigenetics: Two Sides of the Same Coin? Cancer Cell. 2012;22:9\u201320. doi: 10.1016/j.ccr.2012.06.008.", "ArticleIdList": ["10.1016/j.ccr.2012.06.008", "PMC3396881", "22789535"]}, {"Citation": "Pfister S.X., Ashworth A. Marked for Death: Targeting Epigenetic Changes in Cancer. Nat. Rev. Drug Discov. 2017;16:241\u2013263. doi: 10.1038/nrd.2016.256.", "ArticleIdList": ["10.1038/nrd.2016.256", "28280262"]}, {"Citation": "Holliday R. DNA Methylation and Epigenetic Inheritance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1990;326:329\u2013338. doi: 10.1016/S1046-2023(02)00072-5.", "ArticleIdList": ["10.1016/S1046-2023(02)00072-5", "1968668"]}, {"Citation": "Kristensen L.S., Nielsen H.M., Hansen L.L. Epigenetics and Cancer Treatment. Eur. J. Pharmacol. 2009;625:131\u2013142. doi: 10.1016/j.ejphar.2009.10.011.", "ArticleIdList": ["10.1016/j.ejphar.2009.10.011", "19836388"]}, {"Citation": "Karimzadeh M.R., Pourdavoud P., Ehtesham N., Qadbeigi M., Asl M.M., Alani B., Mosallaei M., Pakzad B. Regulation of DNA Methylation Machinery by Epi-MiRNAs in Human Cancer: Emerging New Targets in Cancer Therapy. Cancer Gene Ther. 2021;28:157\u2013174. doi: 10.1038/s41417-020-00210-7.", "ArticleIdList": ["10.1038/s41417-020-00210-7", "32773776"]}, {"Citation": "Ross J.P., Rand K.N., Molloy P.L. Hypomethylation of Repeated DNA Sequences in Cancer. Epigenomics. 2010;2:245\u2013269. doi: 10.2217/epi.10.2.", "ArticleIdList": ["10.2217/epi.10.2", "22121873"]}, {"Citation": "Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation. Science. 2003;300:455. doi: 10.1126/science.1083557.", "ArticleIdList": ["10.1126/science.1083557", "12702868"]}, {"Citation": "Esteller M., Corn P.G., Baylin S.B., Herman J.G. A Gene Hypermethylation Profile of Human Cancer. Cancer Res. 2001;61:3225\u20133229.", "ArticleIdList": ["11309270"]}, {"Citation": "He J., Zhou M., Li X., Gu S., Cao Y., Xing T., Chen W., Chu C., Gu F., Zhou J. SLC34A2 Simultaneously Promotes Papillary Thyroid Carcinoma Growth and Invasion through Distinct Mechanisms. Oncogene. 2020;39:2658\u20132675. doi: 10.1038/s41388-020-1181-z.", "ArticleIdList": ["10.1038/s41388-020-1181-z", "32005974"]}, {"Citation": "Sastry N.G., Wan X., Huang T., Alvarez A.A., Pangeni R.P., Song X., James C.D., Horbinski C.M., Brennan C.W., Nakano I. LY6K Promotes Glioblastoma Tumorigenicity via CAV-1\u2013Mediated ERK1/2 Signaling Enhancement. Neuro-Oncol. 2020;22:1315\u20131326. doi: 10.1093/neuonc/noaa032.", "ArticleIdList": ["10.1093/neuonc/noaa032", "PMC7523463", "32055849"]}, {"Citation": "Xiao C., Wu G., Zhou Z., Zhang X., Wang Y., Song G., Ding E., Sun X., Zhong L., Li S. RBBP6, a RING Finger-Domain E3 Ubiquitin Ligase, Induces Epithelial\u2013Mesenchymal Transition and Promotes Metastasis of Colorectal Cancer. Cell Death Dis. 2019;10:833. doi: 10.1038/s41419-019-2070-7.", "ArticleIdList": ["10.1038/s41419-019-2070-7", "PMC6828677", "31685801"]}, {"Citation": "Eads C.A., Lord R.V., Kurumboor S.K., Wickramasinghe K., Skinner M.L., Long T.I., Peters J.H., DeMeester T.R., Danenberg K.D., Danenberg P.V. Fields of Aberrant CpG Island Hypermethylation in Barrett\u2019s Esophagus and Associated Adenocarcinoma. Cancer Res. 2000;60:5021\u20135026.", "ArticleIdList": ["11016622"]}, {"Citation": "Issa J.-P.J., Ahuja N., Toyota M., Bronner M.P., Brentnall T.A. Accelerated Age-Related CpG Island Methylation in Ulcerative Colitis. Cancer Res. 2001;61:3573\u20133577.", "ArticleIdList": ["11325821"]}, {"Citation": "Greger V., Passarge E., H\u00f6pping W., Messmer E., Horsthemke B. Epigenetic Changes May Contribute to the Formation and Spontaneous Regression of Retinoblastoma. Hum. Genet. 1989;83:155\u2013158. doi: 10.1007/BF00286709.", "ArticleIdList": ["10.1007/BF00286709", "2550354"]}, {"Citation": "Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.S., Gnarra J.R., Linehan W.M. Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma. Proc. Natl. Acad. Sci. USA. 1994;91:9700\u20139704. doi: 10.1073/pnas.91.21.9700.", "ArticleIdList": ["10.1073/pnas.91.21.9700", "PMC44884", "7937876"]}, {"Citation": "Gonzalez-Zulueta M., Bender C.M., Yang A.S., Nguyen T., Beart R.W., Van Tornout J.M., Jones P.A. Methylation of the 5\u2032 CpG Island of the P16/CDKN2 Tumor Suppressor Gene in Normal and Transformed Human Tissues Correlates with Gene Silencing. Cancer Res. 1995;55:4531\u20134535.", "ArticleIdList": ["7553622"]}, {"Citation": "Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the HMLH1 Promoter Correlates with Lack of Expression of HMLH1 in Sporadic Colon Tumors and Mismatch Repair-Defective Human Tumor Cell Lines. Cancer Res. 1997;57:808\u2013811.", "ArticleIdList": ["9041175"]}, {"Citation": "Richter A.M., Woods M.L., K\u00fcster M.M., Walesch S.K., Braun T., Boettger T., Dammann R.H. RASSF10 Is Frequently Epigenetically Inactivated in Kidney Cancer and Its Knockout Promotes Neoplasia in Cancer Prone Mice. Oncogene. 2020;39:3114\u20133127. doi: 10.1038/s41388-020-1195-6.", "ArticleIdList": ["10.1038/s41388-020-1195-6", "PMC7142015", "32047266"]}, {"Citation": "Yu Z., Feng J., Wang W., Deng Z., Zhang Y., Xiao L., Wang Z., Liu C., Liu Q., Chen S. The EGFR-ZNF263 Signaling Axis Silences SIX3 in Glioblastoma Epigenetically. Oncogene. 2020;39:3163\u20133178. doi: 10.1038/s41388-020-1206-7.", "ArticleIdList": ["10.1038/s41388-020-1206-7", "PMC7142014", "32051553"]}, {"Citation": "Marini A., Mirmohammadsadegh A., Nambiar S., Gustrau A., Ruzicka T., Hengge U.R. Epigenetic Inactivation of Tumor Suppressor Genes in Serum of Patients with Cutaneous Melanoma. J. Investig. Dermatol. 2006;126:422\u2013431. doi: 10.1038/sj.jid.5700073.", "ArticleIdList": ["10.1038/sj.jid.5700073", "16374457"]}, {"Citation": "Mirmohammadsadegh A., Marini A., Nambiar S., Hassan M., Tannapfel A., Ruzicka T., Hengge U.R. Epigenetic Silencing of the PTEN Gene in Melanoma. Cancer Res. 2006;66:6546\u20136552. doi: 10.1158/0008-5472.CAN-06-0384.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0384", "16818626"]}, {"Citation": "Majumdar S., Buckles E., Estrada J., Koochekpour S. Aberrant DNA Methylation and Prostate Cancer. Curr. Genom. 2011;12:486\u2013505. doi: 10.2174/138920211797904061.", "ArticleIdList": ["10.2174/138920211797904061", "PMC3219844", "22547956"]}, {"Citation": "Bell A., Bell D., Weber R.S., El-Naggar A.K. CpG Island Methylation Profiling in Human Salivary Gland Adenoid Cystic Carcinoma. Cancer. 2011;117:2898\u20132909. doi: 10.1002/cncr.25818.", "ArticleIdList": ["10.1002/cncr.25818", "PMC3123690", "21692051"]}, {"Citation": "He S., Wang F., Yang L., Guo C., Wan R., Ke A., Xu L., Hu G., Xu X., Shen J. Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer. PLoS ONE. 2011;6:e27684. doi: 10.1371/journal.pone.0027684.", "ArticleIdList": ["10.1371/journal.pone.0027684", "PMC3215738", "22110720"]}, {"Citation": "Baylin S.B., Ohm J.E. Epigenetic Gene Silencing in Cancer\u2013a Mechanism for Early Oncogenic Pathway Addiction? Nat. Rev. Cancer. 2006;6:107\u2013116. doi: 10.1038/nrc1799.", "ArticleIdList": ["10.1038/nrc1799", "16491070"]}, {"Citation": "Markl I.D., Cheng J., Liang G., Shibata D., Laird P.W., Jones P.A. Global and Gene-Specific Epigenetic Patterns in Human Bladder Cancer Genomes Are Relatively Stable in Vivo and in Vitro over Time. Cancer Res. 2001;61:5875\u20135884.", "ArticleIdList": ["11479229"]}, {"Citation": "Nacev B.A., Feng L., Bagert J.D., Lemiesz A.E., Gao J., Soshnev A.A., Kundra R., Schultz N., Muir T.W., Allis C.D. The Expanding Landscape of \u2018Oncohistone\u2019Mutations in Human Cancers. Nature. 2019;567:473\u2013478. doi: 10.1038/s41586-019-1038-1.", "ArticleIdList": ["10.1038/s41586-019-1038-1", "PMC6512987", "30894748"]}, {"Citation": "Zhao S., Bellone S., Lopez S., Thakral D., Schwab C., English D.P., Black J., Cocco E., Choi J., Zammataro L. Mutational Landscape of Uterine and Ovarian Carcinosarcomas Implicates Histone Genes in Epithelial\u2013Mesenchymal Transition. Proc. Natl. Acad. Sci. USA. 2016;113:12238\u201312243. doi: 10.1073/pnas.1614120113.", "ArticleIdList": ["10.1073/pnas.1614120113", "PMC5087050", "27791010"]}, {"Citation": "Schwartzentruber J., Korshunov A., Liu X.-Y., Jones D.T., Pfaff E., Jacob K., Sturm D., Fontebasso A.M., Quang D.-A.K., T\u00f6njes M. Driver Mutations in Histone H3. 3 and Chromatin Remodelling Genes in Paediatric Glioblastoma. Nature. 2012;482:226\u2013231. doi: 10.1038/nature10833.", "ArticleIdList": ["10.1038/nature10833", "22286061"]}, {"Citation": "Wu G., Broniscer A., McEachron T.A., Lu C., Paugh B.S., Becksfort J., Qu C., Ding L., Huether R., Parker M.S. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project. Somatic Histone H3 Alterations in Pediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas. Nat. Genet. 2012;44:251\u2013253.", "ArticleIdList": ["PMC3288377", "22286216"]}, {"Citation": "Koelsche C., Schrimpf D., Tharun L., Roth E., Sturm D., Jones D.T., Renker E.-K., Sill M., Baude A., Sahm F. Histone 3.3 Hotspot Mutations in Conventional Osteosarcomas: A Comprehensive Clinical and Molecular Characterization of Six H3F3A Mutated Cases. Clin. Sarcoma Res. 2017;7:9. doi: 10.1186/s13569-017-0075-5.", "ArticleIdList": ["10.1186/s13569-017-0075-5", "PMC5418758", "28484590"]}, {"Citation": "Lutsik P., Baude A., Mancarella D., \u00d6z S., K\u00fchn A., Toth R., Hey J., Toprak U.H., Lim J., Nguyen V.H. Globally Altered Epigenetic Landscape and Delayed Osteogenic Differentiation in H3. 3-G34W-Mutant Giant Cell Tumor of Bone. Nat. Commun. 2020;11:5414. doi: 10.1038/s41467-020-18955-y.", "ArticleIdList": ["10.1038/s41467-020-18955-y", "PMC7591516", "33110075"]}, {"Citation": "Mohammad H.P., Barbash O., Creasy C.L. Targeting Epigenetic Modifications in Cancer Therapy: Erasing the Roadmap to Cancer. Nat. Med. 2019;25:403\u2013418. doi: 10.1038/s41591-019-0376-8.", "ArticleIdList": ["10.1038/s41591-019-0376-8", "30842676"]}, {"Citation": "Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K. Loss of Acetylation at Lys16 and Trimethylation at Lys20 of Histone H4 Is a Common Hallmark of Human Cancer. Nat. Genet. 2005;37:391\u2013400. doi: 10.1038/ng1531.", "ArticleIdList": ["10.1038/ng1531", "15765097"]}, {"Citation": "Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S.K. Global Histone Modification Patterns Predict Risk of Prostate Cancer Recurrence. Nature. 2005;435:1262\u20131266. doi: 10.1038/nature03672.", "ArticleIdList": ["10.1038/nature03672", "15988529"]}, {"Citation": "Prachayasittikul V., Prathipati P., Pratiwi R., Phanus-Umporn C., Malik A.A., Schaduangrat N., Seenprachawong K., Wongchitrat P., Supokawej A., Prachayasittikul V. Exploring the Epigenetic Drug Discovery Landscape. Expert Opin. Drug Discov. 2017;12:345\u2013362. doi: 10.1080/17460441.2017.1295954.", "ArticleIdList": ["10.1080/17460441.2017.1295954", "28276705"]}, {"Citation": "Kubicek S., Gilbert J.C., Fomina-Yadlin D., Gitlin A.D., Yuan Y., Wagner F.F., Holson E.B., Luo T., Lewis T.A., Taylor B. Chromatin-Targeting Small Molecules Cause Class-Specific Transcriptional Changes in Pancreatic Endocrine Cells. Proc. Natl. Acad. Sci. USA. 2012;109:5364\u20135369. doi: 10.1073/pnas.1201079109.", "ArticleIdList": ["10.1073/pnas.1201079109", "PMC3325696", "22434908"]}, {"Citation": "Barski A., Cuddapah S., Cui K., Roh T.-Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-Resolution Profiling of Histone Methylations in the Human Genome. Cell. 2007;129:823\u2013837. doi: 10.1016/j.cell.2007.05.009.", "ArticleIdList": ["10.1016/j.cell.2007.05.009", "17512414"]}, {"Citation": "Bradbury C.A., Khanim F.L., Hayden R., Bunce C.M., White D.A., Drayson M.T., Craddock C., Turner B.M. Histone Deacetylases in Acute Myeloid Leukaemia Show a Distinctive Pattern of Expression That Changes Selectively in Response to Deacetylase Inhibitors. Leukemia. 2005;19:1751\u20131759. doi: 10.1038/sj.leu.2403910.", "ArticleIdList": ["10.1038/sj.leu.2403910", "16121216"]}, {"Citation": "Fang D., Gan H., Cheng L., Lee J.-H., Zhou H., Sarkaria J.N., Daniels D.J., Zhang Z. H3. 3K27M Mutant Proteins Reprogram Epigenome by Sequestering the PRC2 Complex to Poised Enhancers. Elife. 2018;7:e36696. doi: 10.7554/eLife.36696.", "ArticleIdList": ["10.7554/eLife.36696", "PMC6033537", "29932419"]}, {"Citation": "Larson J.D., Kasper L.H., Paugh B.S., Jin H., Wu G., Kwon C.-H., Fan Y., Shaw T.I., Silveira A.B., Qu C. Histone H3. 3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer Cell. 2019;35:140\u2013155. doi: 10.1016/j.ccell.2018.11.015.", "ArticleIdList": ["10.1016/j.ccell.2018.11.015", "PMC6570409", "30595505"]}, {"Citation": "Chase A., Cross N.C. Aberrations of EZH2 in Cancer. Clin. Cancer Res. 2011;17:2613\u20132618. doi: 10.1158/1078-0432.CCR-10-2156.", "ArticleIdList": ["10.1158/1078-0432.CCR-10-2156", "21367748"]}, {"Citation": "Fang D., Gan H., Lee J.-H., Han J., Wang Z., Riester S.M., Jin L., Chen J., Zhou H., Wang J. The Histone H3. 3K36M Mutation Reprograms the Epigenome of Chondroblastomas. Science. 2016;352:1344\u20131348. doi: 10.1126/science.aae0065.", "ArticleIdList": ["10.1126/science.aae0065", "PMC5460624", "27229140"]}, {"Citation": "Lu C., Jain S.U., Hoelper D., Bechet D., Molden R.C., Ran L., Murphy D., Venneti S., Hameed M., Pawel B.R. Histone H3K36 Mutations Promote Sarcomagenesis through Altered Histone Methylation Landscape. Science. 2016;352:844\u2013849. doi: 10.1126/science.aac7272.", "ArticleIdList": ["10.1126/science.aac7272", "PMC4928577", "27174990"]}, {"Citation": "Lhoumaud P., Badri S., Rodriguez-Hernaez J., Sakellaropoulos T., Sethia G., Kloetgen A., Cornwell M., Bhattacharyya S., Ay F., Bonneau R. NSD2 Overexpression Drives Clustered Chromatin and Transcriptional Changes in a Subset of Insulated Domains. Nat. Commun. 2019;10:4843. doi: 10.1038/s41467-019-12811-4.", "ArticleIdList": ["10.1038/s41467-019-12811-4", "PMC6813313", "31649247"]}, {"Citation": "Karatas H., Townsend E.C., Cao F., Chen Y., Bernard D., Liu L., Lei M., Dou Y., Wang S. High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein\u2013Protein Interaction. J. Am. Chem. Soc. 2013;135:669\u2013682. doi: 10.1021/ja306028q.", "ArticleIdList": ["10.1021/ja306028q", "PMC5180416", "23210835"]}, {"Citation": "Xhemalce B., Dawson M.A., Bannister A.J. Reviews in Cell Biology and Molecular Medicine. Wiley; Hoboken, NJ, USA: 2006. Histone Modifications."}, {"Citation": "Narita T., Weinert B.T., Choudhary C. Functions and Mechanisms of Non-Histone Protein Acetylation. Nat. Rev. Mol. Cell Biol. 2019;20:156\u2013174. doi: 10.1038/s41580-018-0081-3.", "ArticleIdList": ["10.1038/s41580-018-0081-3", "30467427"]}, {"Citation": "Marmorstein R. Structure of Histone Acetyltransferases. J. Mol. Biol. 2001;311:433\u2013444. doi: 10.1006/jmbi.2001.4859.", "ArticleIdList": ["10.1006/jmbi.2001.4859", "11492997"]}, {"Citation": "Calcagno D.Q., Wisnieski F., Mota E.R., Maia de Sousa S.B., Costa da Silva J.M., Leal M.F., Gigek C.O., Santos L.C., Rasmussen L.T., Assump\u00e7\u00e3o P.P. Role of Histone Acetylation in Gastric Cancer: Implications of Dietetic Compounds and Clinical Perspectives. Epigenomics. 2019;11:349\u2013362. doi: 10.2217/epi-2018-0081.", "ArticleIdList": ["10.2217/epi-2018-0081", "30672330"]}, {"Citation": "Gruber J.J., Geller B., Lipchik A.M., Chen J., Salahudeen A.A., Ram A.N., Ford J.M., Kuo C.J., Snyder M.P. HAT1 Coordinates Histone Production and Acetylation via H4 Promoter Binding. Mol. Cell. 2019;75:711\u2013724. doi: 10.1016/j.molcel.2019.05.034.", "ArticleIdList": ["10.1016/j.molcel.2019.05.034", "PMC6707831", "31278053"]}, {"Citation": "Shanmugam M.K., Arfuso F., Arumugam S., Chinnathambi A., Bian J., Warrier S., Wang L.Z., Kumar A.P., Ahn K.S., Sethi G. Correction: Role of Novel Histone Modifications in Cancer. Oncotarget. 2018;9:19460. doi: 10.18632/oncotarget.25152.", "ArticleIdList": ["10.18632/oncotarget.25152", "PMC5922411", "29722359"]}, {"Citation": "Pasqualucci L., Dominguez-Sola D., Chiarenza A., Fabbri G., Grunn A., Trifonov V., Kasper L.H., Lerach S., Tang H., Ma J. Inactivating Mutations of Acetyltransferase Genes in B-Cell Lymphoma. Nature. 2011;471:189\u2013195. doi: 10.1038/nature09730.", "ArticleIdList": ["10.1038/nature09730", "PMC3271441", "21390126"]}, {"Citation": "Chen S., Yin C., Lao T., Liang D., He D., Wang C., Sang N. AMPK-HDAC5 Pathway Facilitates Nuclear Accumulation of HIF-1\u03b1 and Functional Activation of HIF-1 by Deacetylating Hsp70 in the Cytosol. Cell Cycle. 2015;14:2520\u20132536. doi: 10.1080/15384101.2015.1055426.", "ArticleIdList": ["10.1080/15384101.2015.1055426", "PMC4614078", "26061431"]}, {"Citation": "Li J., Huang C., Xiong T., Zhuang C., Zhuang C., Li Y., Ye J., Gui Y. A CRISPR Interference of CBP and P300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro. Int. J. Biol. Sci. 2019;15:1276. doi: 10.7150/ijbs.32332.", "ArticleIdList": ["10.7150/ijbs.32332", "PMC6567804", "31223286"]}, {"Citation": "Davis P.K., Brachmann R.K. Chromatin Remodeling and Cancer. Cancer Biol. Ther. 2003;2:23\u201330. doi: 10.4161/cbt.189.", "ArticleIdList": ["10.4161/cbt.189", "12673113"]}, {"Citation": "Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions. Science. 2009;325:834\u2013840. doi: 10.1126/science.1175371.", "ArticleIdList": ["10.1126/science.1175371", "19608861"]}, {"Citation": "Cohen P. The Origins of Protein Phosphorylation. Nat. Cell Biol. 2002;4:E127\u2013E130. doi: 10.1038/ncb0502-e127.", "ArticleIdList": ["10.1038/ncb0502-e127", "11988757"]}, {"Citation": "Fabbro D., Cowan-Jacob S.W., Moebitz H. Ten Things You Should Know about Protein Kinases: IUPHAR R Eview 14. Br. J. Pharmacol. 2015;172:2675\u20132700. doi: 10.1111/bph.13096.", "ArticleIdList": ["10.1111/bph.13096", "PMC4439867", "25630872"]}, {"Citation": "Glickman M.H., Ciechanover A. The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction. Physiol. Rev. 2002;82:373\u2013428. doi: 10.1152/physrev.00027.2001.", "ArticleIdList": ["10.1152/physrev.00027.2001", "11917093"]}, {"Citation": "Seeler J.-S., Dejean A. SUMO and the Robustness of Cancer. Nat. Rev. Cancer. 2017;17:184\u2013197. doi: 10.1038/nrc.2016.143.", "ArticleIdList": ["10.1038/nrc.2016.143", "28134258"]}, {"Citation": "Ryan B.M., Robles A.I., Harris C.C. Genetic Variation in MicroRNA Networks: The Implications for Cancer Research. Nat. Rev. Cancer. 2010;10:389\u2013402. doi: 10.1038/nrc2867.", "ArticleIdList": ["10.1038/nrc2867", "PMC2950312", "20495573"]}, {"Citation": "Kasinski A.L., Slack F.J. MiRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-Ras and P53-Induced Mouse Model of Lung Adenocarcinoma. Cancer Res. 2012;72:5576\u20135587. doi: 10.1158/0008-5472.CAN-12-2001.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-2001", "PMC3488137", "22964582"]}, {"Citation": "Esquela-Kerscher A., Slack F.J. Oncomirs\u2014MicroRNAs with a Role in Cancer. Nat. Rev. Cancer. 2006;6:259\u2013269. doi: 10.1038/nrc1840.", "ArticleIdList": ["10.1038/nrc1840", "16557279"]}, {"Citation": "Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K. Frequent Deletions and Down-Regulation of Micro-RNA Genes MiR15 and MiR16 at 13q14 in Chronic Lymphocytic Leukemia. Proc. Natl. Acad. Sci. USA. 2002;99:15524\u201315529. doi: 10.1073/pnas.242606799.", "ArticleIdList": ["10.1073/pnas.242606799", "PMC137750", "12434020"]}, {"Citation": "Kasinski A.L., Slack F.J. MicroRNAs En Route to the Clinic: Progress in Validating and Targeting MicroRNAs for Cancer Therapy. Nat. Rev. Cancer. 2011;11:849\u2013864. doi: 10.1038/nrc3166.", "ArticleIdList": ["10.1038/nrc3166", "PMC4314215", "22113163"]}, {"Citation": "Friedman J.M., Liang G., Liu C.-C., Wolff E.M., Tsai Y.C., Ye W., Zhou X., Jones P.A. The Putative Tumor Suppressor MicroRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2. Cancer Res. 2009;69:2623\u20132629. doi: 10.1158/0008-5472.CAN-08-3114.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-3114", "19258506"]}, {"Citation": "Varambally S., Cao Q., Mani R.-S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K. Genomic Loss of MicroRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer. Science. 2008;322:1695\u20131699. doi: 10.1126/science.1165395.", "ArticleIdList": ["10.1126/science.1165395", "PMC2684823", "19008416"]}, {"Citation": "Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C. MicroRNA-29 Family Reverts Aberrant Methylation in Lung Cancer by Targeting DNA Methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA. 2007;104:15805\u201315810. doi: 10.1073/pnas.0707628104.", "ArticleIdList": ["10.1073/pnas.0707628104", "PMC2000384", "17890317"]}, {"Citation": "Bandres E., Agirre X., Bitarte N., Ramirez N., Zarate R., Roman-Gomez J., Prosper F., Garcia-Foncillas J. Epigenetic Regulation of MicroRNA Expression in Colorectal Cancer. Int. J. Cancer. 2009;125:2737\u20132743. doi: 10.1002/ijc.24638.", "ArticleIdList": ["10.1002/ijc.24638", "19521961"]}, {"Citation": "Chen P., Zhao X., Ma L. Downregulation of MicroRNA-100 Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma. Mol. Cell. Biochem. 2013;383:49\u201358. doi: 10.1007/s11010-013-1753-0.", "ArticleIdList": ["10.1007/s11010-013-1753-0", "23842624"]}, {"Citation": "Lehmann U., Hasemeier B., Christgen M., M\u00fcller M., R\u00f6mermann D., L\u00e4nger F., Kreipe H. Epigenetic Inactivation of MicroRNA Gene Hsa-Mir-9-1 in Human Breast Cancer. J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2008;214:17\u201324.", "ArticleIdList": ["17948228"]}, {"Citation": "Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., Jones P.A. Specific Activation of MicroRNA-127 with Downregulation of the Proto-Oncogene BCL6 by Chromatin-Modifying Drugs in Human Cancer Cells. Cancer Cell. 2006;9:435\u2013443. doi: 10.1016/j.ccr.2006.04.020.", "ArticleIdList": ["10.1016/j.ccr.2006.04.020", "16766263"]}, {"Citation": "Rezaei T., Amini M., Hashemi Z.S., Mansoori B., Rezaei S., Karami H., Mosafer J., Mokhtarzadeh A., Baradaran B. MicroRNA-181 Serves as a Dual-Role Regulator in the Development of Human Cancers. Free. Radic. Biol. Med. 2020;152:432\u2013454. doi: 10.1016/j.freeradbiomed.2019.12.043.", "ArticleIdList": ["10.1016/j.freeradbiomed.2019.12.043", "31899343"]}, {"Citation": "Chiba S. Dysregulation of TET2 in Hematologic Malignancies. Int. J. Hematol. 2017;105:17\u201322. doi: 10.1007/s12185-016-2122-z.", "ArticleIdList": ["10.1007/s12185-016-2122-z", "27848178"]}, {"Citation": "Inomata M., Tagawa H., Guo Y.-M., Kameoka Y., Takahashi N., Sawada K. MicroRNA-17-92 down-Regulates Expression of Distinct Targets in Different B-Cell Lymphoma Subtypes. Blood J. Am. Soc. Hematol. 2009;113:396\u2013402. doi: 10.1182/blood-2008-07-163907.", "ArticleIdList": ["10.1182/blood-2008-07-163907", "18941111"]}, {"Citation": "Wang H., An X., Yu H., Zhang S., Tang B., Zhang X., Li Z. MiR-29b/TET1/ZEB2 Signaling Axis Regulates Metastatic Properties and Epithelial-Mesenchymal Transition in Breast Cancer Cells. Oncotarget. 2017;8:102119. doi: 10.18632/oncotarget.22183.", "ArticleIdList": ["10.18632/oncotarget.22183", "PMC5731940", "29254230"]}, {"Citation": "Lin H.-Y., Chen C.-S., Lin S.-P., Weng J.-R., Chen C.-S. Targeting Histone Deacetylase in Cancer Therapy. Med. Res. Rev. 2006;26:397\u2013413. doi: 10.1002/med.20056.", "ArticleIdList": ["10.1002/med.20056", "16450343"]}, {"Citation": "Delcuve G.P., Khan D.H., Davie J.R. Roles of Histone Deacetylases in Epigenetic Regulation: Emerging Paradigms from Studies with Inhibitors. Clin. Epigenetics. 2012;4:5. doi: 10.1186/1868-7083-4-5.", "ArticleIdList": ["10.1186/1868-7083-4-5", "PMC3320549", "22414492"]}, {"Citation": "Ropero S., Esteller M. The Role of Histone Deacetylases (HDACs) in Human Cancer. Mol. Oncol. 2007;1:19\u201325. doi: 10.1016/j.molonc.2007.01.001.", "ArticleIdList": ["10.1016/j.molonc.2007.01.001", "PMC5543853", "19383284"]}, {"Citation": "Mercurio C., Minucci S., Pelicci P.G. Histone Deacetylases and Epigenetic Therapies of Hematological Malignancies. Pharmacol. Res. 2010;62:18\u201334. doi: 10.1016/j.phrs.2010.02.010.", "ArticleIdList": ["10.1016/j.phrs.2010.02.010", "20219679"]}, {"Citation": "Halkidou K., Gaughan L., Cook S., Leung H.Y., Neal D.E., Robson C.N. Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer. Prostate. 2004;59:177\u2013189. doi: 10.1002/pros.20022.", "ArticleIdList": ["10.1002/pros.20022", "15042618"]}, {"Citation": "Wilson A.J., Byun D.-S., Popova N., Murray L.B., L\u2019Italien K., Sowa Y., Arango D., Velcich A., Augenlicht L.H., Mariadason J.M. Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and P21 Expression and Are Deregulated in Human Colon Cancer. J. Biol. Chem. 2006;281:13548\u201313558. doi: 10.1074/jbc.M510023200.", "ArticleIdList": ["10.1074/jbc.M510023200", "16533812"]}, {"Citation": "Choi J.-H., Kwon H.J., Yoon B.-I., Kim J.-H., Han S.U., Joo H.J., Kim D.-Y. Expression Profile of Histone Deacetylase 1 in Gastric Cancer Tissues. Jpn. J. Cancer Res. 2001;92:1300\u20131304. doi: 10.1111/j.1349-7006.2001.tb02153.x.", "ArticleIdList": ["10.1111/j.1349-7006.2001.tb02153.x", "PMC5926683", "11749695"]}, {"Citation": "Zhang Z., Yamashita H., Toyama T., Sugiura H., Ando Y., Mita K., Hamaguchi M., Hara Y., Kobayashi S., Iwase H. Quantitation of HDAC1 MRNA Expression in Invasive Carcinoma of the Breast. Breast Cancer Res. Treat. 2005;94:11\u201316. doi: 10.1007/s10549-005-6001-1.", "ArticleIdList": ["10.1007/s10549-005-6001-1", "16172792"]}, {"Citation": "Zhu P., Martin E., Mengwasser J., Schlag P., Janssen K.-P., G\u00f6ttlicher M. Induction of HDAC2 Expression upon Loss of APC in Colorectal Tumorigenesis. Cancer Cell. 2004;5:455\u2013463. doi: 10.1016/S1535-6108(04)00114-X.", "ArticleIdList": ["10.1016/S1535-6108(04)00114-X", "15144953"]}, {"Citation": "Huang B.H., Laban M., Leung C.H., Lee L., Lee C.K., Salto-Tellez M., Raju G.C., Hooi S.C. Inhibition of Histone Deacetylase 2 Increases Apoptosis and P21 Cip1/WAF1 Expression, Independent of Histone Deacetylase 1. Cell Death Differ. 2005;12:395\u2013404. doi: 10.1038/sj.cdd.4401567.", "ArticleIdList": ["10.1038/sj.cdd.4401567", "15665816"]}, {"Citation": "Song J., Noh J.H., Lee J.H., Eun J.W., Ahn Y.M., Kim S.Y., Lee S.H., Park W.S., Yoo N.J., Lee J.Y. Increased Expression of Histone Deacetylase 2 Is Found in Human Gastric Cancer. Apmis. 2005;113:264\u2013268. doi: 10.1111/j.1600-0463.2005.apm_04.x.", "ArticleIdList": ["10.1111/j.1600-0463.2005.apm_04.x", "15865607"]}, {"Citation": "Zhang Z., Yamashita H., Toyama T., Sugiura H., Omoto Y., Ando Y., Mita K., Hamaguchi M., Hayashi S., Iwase H. HDAC6 Expression Is Correlated with Better Survival in Breast Cancer. Clin. Cancer Res. 2004;10:6962\u20136968. doi: 10.1158/1078-0432.CCR-04-0455.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0455", "15501975"]}, {"Citation": "Ropero S., Fraga M.F., Ballestar E., Hamelin R., Yamamoto H., Boix-Chornet M., Caballero R., Alaminos M., Setien F., Paz M.F. A Truncating Mutation of HDAC2 in Human Cancers Confers Resistance to Histone Deacetylase Inhibition. Nat. Genet. 2006;38:566\u2013569. doi: 10.1038/ng1773.", "ArticleIdList": ["10.1038/ng1773", "16642021"]}, {"Citation": "Zimmermann S., Kiefer F., Prudenziati M., Spiller C., Hansen J., Floss T., Wurst W., Minucci S., G\u00f6ttlicher M. Reduced Body Size and Decreased Intestinal Tumor Rates in HDAC2-Mutant Mice. Cancer Res. 2007;67:9047\u20139054. doi: 10.1158/0008-5472.CAN-07-0312.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-0312", "17909008"]}, {"Citation": "Bhaskara S., Chyla B.J., Amann J.M., Knutson S.K., Cortez D., Sun Z.-W., Hiebert S.W. Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control. Mol. Cell. 2008;30:61\u201372. doi: 10.1016/j.molcel.2008.02.030.", "ArticleIdList": ["10.1016/j.molcel.2008.02.030", "PMC2373760", "18406327"]}, {"Citation": "Glaser K.B., Li J., Staver M.J., Wei R.-Q., Albert D.H., Davidsen S.K. Role of Class I and Class II Histone Deacetylases in Carcinoma Cells Using SiRNA. Biochem. Biophys. Res. Commun. 2003;310:529\u2013536. doi: 10.1016/j.bbrc.2003.09.043.", "ArticleIdList": ["10.1016/j.bbrc.2003.09.043", "14521942"]}, {"Citation": "Inoue S., Mai A., Dyer M.J., Cohen G.M. Inhibition of Histone Deacetylase Class I but Not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor\u2013Related Apoptosis-Inducing Ligand\u2013Induced Apoptosis. Cancer Res. 2006;66:6785\u20136792. doi: 10.1158/0008-5472.CAN-05-4563.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-4563", "16818655"]}, {"Citation": "Weichert W., R\u00f6ske A., Niesporek S., Noske A., Buckendahl A.-C., Dietel M., Gekeler V., Boehm M., Beckers T., Denkert C. Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases in Vitro and in Vivo. Clin. Cancer Res. 2008;14:1669\u20131677. doi: 10.1158/1078-0432.CCR-07-0990.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-0990", "18347167"]}, {"Citation": "Wilson A.J., Byun D.-S., Nasser S., Murray L.B., Ayyanar K., Arango D., Figueroa M., Melnick A., Kao G.D., Augenlicht L.H. HDAC4 Promotes Growth of Colon Cancer Cells via Repression of P21. Mol. Biol. Cell. 2008;19:4062\u20134075. doi: 10.1091/mbc.e08-02-0139.", "ArticleIdList": ["10.1091/mbc.e08-02-0139", "PMC2555950", "18632985"]}, {"Citation": "Park J.-H., Kim S.-H., Choi M.-C., Lee J., Oh D.-Y., Im S.-A., Bang Y.-J., Kim T.-Y. Class II Histone Deacetylases Play Pivotal Roles in Heat Shock Protein 90-Mediated Proteasomal Degradation of Vascular Endothelial Growth Factor Receptors. Biochem. Biophys. Res. Commun. 2008;368:318\u2013322. doi: 10.1016/j.bbrc.2008.01.056.", "ArticleIdList": ["10.1016/j.bbrc.2008.01.056", "18211808"]}, {"Citation": "Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-\u039aB-Dependent Transcription and Cell Survival by the SIRT1 Deacetylase. EMBO J. 2004;23:2369\u20132380. doi: 10.1038/sj.emboj.7600244.", "ArticleIdList": ["10.1038/sj.emboj.7600244", "PMC423286", "15152190"]}, {"Citation": "Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M., Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P. Composition and Histone Substrates of Polycomb Repressive Group Complexes Change during Cellular Differentiation. Proc. Natl. Acad. Sci. USA. 2005;102:1859\u20131864. doi: 10.1073/pnas.0409875102.", "ArticleIdList": ["10.1073/pnas.0409875102", "PMC548563", "15684044"]}, {"Citation": "Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O. HDAC6 Rescues Neurodegeneration and Provides an Essential Link between Autophagy and the UPS. Nature. 2007;447:860\u2013864. doi: 10.1038/nature05853.", "ArticleIdList": ["10.1038/nature05853", "17568747"]}, {"Citation": "Cheng H.-L., Mostoslavsky R., Saito S., Manis J.P., Gu Y., Patel P., Bronson R., Appella E., Alt F.W., Chua K.F. Developmental Defects and P53 Hyperacetylation in Sir2 Homolog (SIRT1)-Deficient Mice. Proc. Natl. Acad. Sci. USA. 2003;100:10794\u201310799. doi: 10.1073/pnas.1934713100.", "ArticleIdList": ["10.1073/pnas.1934713100", "PMC196882", "12960381"]}, {"Citation": "McBurney M.W., Yang X., Jardine K., Hixon M., Boekelheide K., Webb J.R., Lansdorp P.M., Lemieux M. The Mammalian SIR2\u03b1 Protein Has a Role in Embryogenesis and Gametogenesis. Mol. Cell. Biol. 2003;23:38\u201354. doi: 10.1128/MCB.23.1.38-54.2003.", "ArticleIdList": ["10.1128/MCB.23.1.38-54.2003", "PMC140671", "12482959"]}, {"Citation": "Wang R.-H., Sengupta K., Li C., Kim H.-S., Cao L., Xiao C., Kim S., Xu X., Zheng Y., Chilton B. Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice. Cancer Cell. 2008;14:312\u2013323. doi: 10.1016/j.ccr.2008.09.001.", "ArticleIdList": ["10.1016/j.ccr.2008.09.001", "PMC2643030", "18835033"]}, {"Citation": "Saunders L.R., Verdin E. Sirtuins: Critical Regulators at the Crossroads between Cancer and Aging. Oncogene. 2007;26:5489\u20135504. doi: 10.1038/sj.onc.1210616.", "ArticleIdList": ["10.1038/sj.onc.1210616", "17694089"]}, {"Citation": "Hiratsuka M., Inoue T., Toda T., Kimura N., Shirayoshi Y., Kamitani H., Watanabe T., Ohama E., Tahimic C.G., Kurimasa A. Proteomics-Based Identification of Differentially Expressed Genes in Human Gliomas: Down-Regulation of SIRT2 Gene. Biochem. Biophys. Res. Commun. 2003;309:558\u2013566. doi: 10.1016/j.bbrc.2003.08.029.", "ArticleIdList": ["10.1016/j.bbrc.2003.08.029", "12963026"]}, {"Citation": "Michan S., Sinclair D. Sirtuins in Mammals: Insights into Their Biological Function. Biochem. J. 2007;404:1\u201313. doi: 10.1042/BJ20070140.", "ArticleIdList": ["10.1042/BJ20070140", "PMC2753453", "17447894"]}, {"Citation": "Lee Y.-S., Lim K.-H., Guo X., Kawaguchi Y., Gao Y., Barrientos T., Ordentlich P., Wang X.-F., Counter C.M., Yao T.-P. The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis. Cancer Res. 2008;68:7561\u20137569. doi: 10.1158/0008-5472.CAN-08-0188.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-0188", "PMC2978070", "18794144"]}, {"Citation": "Mottet D., Pirotte S., Lamour V., Hagedorn M., Javerzat S., Bikfalvi A., Bellahcene A., Verdin E., Castronovo V. HDAC4 Represses P21 WAF1/Cip1 Expression in Human Cancer Cells through a Sp1-Dependent, P53-Independent Mechanism. Oncogene. 2009;28:243\u2013256. doi: 10.1038/onc.2008.371.", "ArticleIdList": ["10.1038/onc.2008.371", "18850004"]}, {"Citation": "Senese S., Zaragoza K., Minardi S., Muradore I., Ronzoni S., Passafaro A., Bernard L., Draetta G.F., Alcalay M., Seiser C. Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation. Mol. Cell. Biol. 2007;27:4784\u20134795. doi: 10.1128/MCB.00494-07.", "ArticleIdList": ["10.1128/MCB.00494-07", "PMC1951481", "17470557"]}, {"Citation": "Draney C., Austin M.C., Leifer A.H., Smith C.J., Kener K.B., Aitken T.J., Hess K.H., Haines A.C., Lett L.A., Hernandez-Carretero A. HDAC1 Overexpression Enhances \u03b2-Cell Proliferation by down-Regulating Cdkn1b/P27. Biochem. J. 2018;475:3997\u20134010. doi: 10.1042/BCJ20180465.", "ArticleIdList": ["10.1042/BCJ20180465", "30322885"]}, {"Citation": "Zhao H., Wang Y., Yang C., Zhou J., Wang L., Yi K., Li Y., Shi J., Kang C., Zeng L. EGFR-VIII Downregulated H2AZK4/7AC Though the PI3K/AKT-HDAC2 Axis to Regulate Cell Cycle Progression. Clin. Transl. Med. 2020;9:10. doi: 10.1186/s40169-020-0260-7.", "ArticleIdList": ["10.1186/s40169-020-0260-7", "PMC6987283", "31993801"]}, {"Citation": "Wei D., Lu T., Ma D., Yu K., Zhang T., Xiong J., Wang W., Zhang Z., Fang Q., Wang J. Synergistic Activity of Imatinib and AR-42 against Chronic Myeloid Leukemia Cells Mainly through HDAC1 Inhibition. Life Sci. 2018;211:224\u2013237. doi: 10.1016/j.lfs.2018.09.040.", "ArticleIdList": ["10.1016/j.lfs.2018.09.040", "30248347"]}, {"Citation": "Jiang Y., Hsieh J. HDAC3 Controls Gap 2/Mitosis Progression in Adult Neural Stem/Progenitor Cells by Regulating CDK1 Levels. Proc. Natl. Acad. Sci. USA. 2014;111:13541\u201313546. doi: 10.1073/pnas.1411939111.", "ArticleIdList": ["10.1073/pnas.1411939111", "PMC4169927", "25161285"]}, {"Citation": "Liu D.-L., Lu L.-L., Dong L.-L., Liu Y., Bian X.-Y., Lian B.-F., Xie L., Wen D., Gao D.-M., Ke A.-W. MiR-17-5p and MiR-20a-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma via Blocking HGF/ERBB3-NF-\u039aB Positive Feedback Loop. Theranostics. 2020;10:3668\u20133683. doi: 10.7150/thno.41365.", "ArticleIdList": ["10.7150/thno.41365", "PMC7069088", "32206115"]}, {"Citation": "Yang J., Li B., Zhao S., Du H., Du Y. Exosomal MiR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1. OncoTargets Ther. 2020;13:6709\u20136720. doi: 10.2147/OTT.S253151.", "ArticleIdList": ["10.2147/OTT.S253151", "PMC7368457", "32764961"]}, {"Citation": "Chen M.-K., Cai M.-Y., Luo R.-Z., Tian X., Liao Q.-M., Zhang X.-Y., Han J.-D. Overexpression of P300 Correlates with Poor Prognosis in Patients with Cutaneous Squamous Cell Carcinoma. Br. J. Dermatol. 2015;172:111\u2013119. doi: 10.1111/bjd.13226.", "ArticleIdList": ["10.1111/bjd.13226", "24975674"]}, {"Citation": "Lin J., Liu Z., Liao S., Li E., Wu X., Zeng W. Elevated MicroRNA-7 Inhibits Proliferation and Tumor Angiogenesis and Promotes Apoptosis of Gastric Cancer Cells via Repression of Raf-1. Cell Cycle. 2020;19:2496\u20132508. doi: 10.1080/15384101.2020.1807670.", "ArticleIdList": ["10.1080/15384101.2020.1807670", "PMC7553585", "32931357"]}, {"Citation": "Leslie P.L., Chao Y.L., Tsai Y.-H., Ghosh S.K., Porrello A., Van Swearingen A.E., Harrison E.B., Cooley B.C., Parker J.S., Carey L.A. Histone Deacetylase 11 Inhibition Promotes Breast Cancer Metastasis from Lymph Nodes. Nat. Commun. 2019;10:4192. doi: 10.1038/s41467-019-12222-5.", "ArticleIdList": ["10.1038/s41467-019-12222-5", "PMC6744422", "31519896"]}, {"Citation": "Patra S., Panigrahi D.P., Praharaj P.P., Bhol C.S., Mahapatra K.K., Mishra S.R., Behera B.P., Jena M., Bhutia S.K. Dysregulation of Histone Deacetylases in Carcinogenesis and Tumor Progression: A Possible Link to Apoptosis and Autophagy. Cell. Mol. Life Sci. 2019;76:3263\u20133282. doi: 10.1007/s00018-019-03098-1.", "ArticleIdList": ["10.1007/s00018-019-03098-1", "30982077"]}, {"Citation": "Atsumi A., Tomita A., Kiyoi H., Naoe T. Histone Deacetylase 3 (HDAC3) Is Recruited to Target Promoters by PML-RAR\u03b1 as a Component of the N-CoR Co-Repressor Complex to Repress Transcription in Vivo. Biochem. Biophys. Res. Commun. 2006;345:1471\u20131480. doi: 10.1016/j.bbrc.2006.05.047.", "ArticleIdList": ["10.1016/j.bbrc.2006.05.047", "16730330"]}, {"Citation": "Chauchereau A., Mathieu M., de Saintignon J., Ferreira R., Pritchard L.L., Mishal Z., Dejean A., Harel-Bellan A. HDAC4 Mediates Transcriptional Repression by the Acute Promyelocytic Leukaemia-Associated Protein PLZF. Oncogene. 2004;23:8777\u20138784. doi: 10.1038/sj.onc.1208128.", "ArticleIdList": ["10.1038/sj.onc.1208128", "15467736"]}, {"Citation": "Wang J., Hoshino T., Redner R.L., Kajigaya S., Liu J.M. ETO, Fusion Partner in t (8; 21) Acute Myeloid Leukemia, Represses Transcription by Interaction with the Human N-CoR/MSin3/HDAC1 Complex. Proc. Natl. Acad. Sci. USA. 1998;95:10860\u201310865. doi: 10.1073/pnas.95.18.10860.", "ArticleIdList": ["10.1073/pnas.95.18.10860", "PMC27986", "9724795"]}, {"Citation": "Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., Downing J.R., Meyers S., Hiebert S.W. ETO, a Target of t (8; 21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds MSin3A through Its Oligomerization Domain. Mol. Cell. Biol. 2001;21:6470\u20136483. doi: 10.1128/MCB.21.19.6470-6483.2001.", "ArticleIdList": ["10.1128/MCB.21.19.6470-6483.2001", "PMC99794", "11533236"]}, {"Citation": "Oehme I., Deubzer H.E., Wegener D., Pickert D., Linke J.-P., Hero B., Kopp-Schneider A., Westermann F., Ulrich S.M., Von Deimling A. Histone Deacetylase 8 in Neuroblastoma Tumorigenesis. Clin. Cancer Res. 2009;15:91\u201399. doi: 10.1158/1078-0432.CCR-08-0684.", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0684", "19118036"]}, {"Citation": "Kolbinger F.R., Koeneke E., Ridinger J., Heimburg T., M\u00fcller M., Bayer T., Sippl W., Jung M., Gunkel N., Miller A.K. The HDAC6/8/10 Inhibitor TH34 Induces DNA Damage-Mediated Cell Death in Human High-Grade Neuroblastoma Cell Lines. Arch. Toxicol. 2018;92:2649\u20132664. doi: 10.1007/s00204-018-2234-8.", "ArticleIdList": ["10.1007/s00204-018-2234-8", "PMC6063332", "29947893"]}, {"Citation": "Miller K.M., Tjeertes J.V., Coates J., Legube G., Polo S.E., Britton S., Jackson S.P. Human HDAC1 and HDAC2 Function in the DNA-Damage Response to Promote DNA Nonhomologous End-Joining. Nat. Struct. Mol. Biol. 2010;17:1144\u20131151. doi: 10.1038/nsmb.1899.", "ArticleIdList": ["10.1038/nsmb.1899", "PMC3018776", "20802485"]}, {"Citation": "Nishimoto K., Niida H., Uchida C., Ohhata T., Kitagawa K., Motegi A., Suda T., Kitagawa M. HDAC3 Is Required for XPC Recruitment and Nucleotide Excision Repair of DNA Damage Induced by UV Irradiation. Mol. Cancer Res. 2020;18:1367\u20131378. doi: 10.1158/1541-7786.MCR-20-0214.", "ArticleIdList": ["10.1158/1541-7786.MCR-20-0214", "32527949"]}, {"Citation": "Liu X., Wang Y., Zhang R., Jin T., Qu L., Jin Q., Zheng J., Sun J., Wu Z., Wang L. HDAC10 Is Positively Associated with PD-L1 Expression and Poor Prognosis in Patients with NSCLC. Front. Oncol. 2020;10:485. doi: 10.3389/fonc.2020.00485.", "ArticleIdList": ["10.3389/fonc.2020.00485", "PMC7186423", "32373519"]}, {"Citation": "Yang W.-C., Bao H.-Y., Liu Y.-Y., Nie Y.-Y., Yang J.-M., Hong P.-Z., Zhang Y. Depsidone Derivatives and a Cyclopeptide Produced by Marine Fungus Aspergillus Unguis under Chemical Induction and by Its Plasma Induced Mutant. Molecules. 2018;23:2245. doi: 10.3390/molecules23092245.", "ArticleIdList": ["10.3390/molecules23092245", "PMC6225302", "30177651"]}, {"Citation": "Zhang M., Xiang S., Joo H.-Y., Wang L., Williams K.A., Liu W., Hu C., Tong D., Haakenson J., Wang C. HDAC6 Deacetylates and Ubiquitinates MSH2 to Maintain Proper Levels of MutS\u03b1. Mol. Cell. 2014;55:31\u201346. doi: 10.1016/j.molcel.2014.04.028.", "ArticleIdList": ["10.1016/j.molcel.2014.04.028", "PMC4188514", "24882211"]}, {"Citation": "Lagunas-Rangel F.A. Current Role of Mammalian Sirtuins in DNA Repair. DNA Repair. 2019;80:85\u201392. doi: 10.1016/j.dnarep.2019.06.009.", "ArticleIdList": ["10.1016/j.dnarep.2019.06.009", "31284230"]}, {"Citation": "Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative Control of P53 by Sir2\u03b1 Promotes Cell Survival under Stress. Cell. 2001;107:137\u2013148. doi: 10.1016/S0092-8674(01)00524-4.", "ArticleIdList": ["10.1016/S0092-8674(01)00524-4", "11672522"]}, {"Citation": "Mao Z., Hine C., Tian X., Van Meter M., Au M., Vaidya A., Seluanov A., Gorbunova V. SIRT6 Promotes DNA Repair under Stress by Activating PARP1. Science. 2011;332:1443\u20131446. doi: 10.1126/science.1202723.", "ArticleIdList": ["10.1126/science.1202723", "PMC5472447", "21680843"]}, {"Citation": "Van Meter M., Simon M., Tombline G., May A., Morello T.D., Hubbard B.P., Bredbenner K., Park R., Sinclair D.A., Bohr V.A. JNK Phosphorylates SIRT6 to Stimulate DNA Double-Strand Break Repair in Response to Oxidative Stress by Recruiting PARP1 to DNA Breaks. Cell Rep. 2016;16:2641\u20132650. doi: 10.1016/j.celrep.2016.08.006.", "ArticleIdList": ["10.1016/j.celrep.2016.08.006", "PMC5089070", "27568560"]}, {"Citation": "Zhang H., Chen S., Jia X., Huang Y., Ji R., Zhao L. Comparation of the Phytotoxicity between Chemically and Green Synthesized Silver Nanoparticles. Sci. Total Environ. 2021;752:142264. doi: 10.1016/j.scitotenv.2020.142264.", "ArticleIdList": ["10.1016/j.scitotenv.2020.142264", "33207511"]}, {"Citation": "Moustakas A., Heldin C.-H. Signaling Networks Guiding Epithelial\u2013Mesenchymal Transitions during Embryogenesis and Cancer Progression. Cancer Sci. 2007;98:1512\u20131520. doi: 10.1111/j.1349-7006.2007.00550.x.", "ArticleIdList": ["10.1111/j.1349-7006.2007.00550.x", "17645776"]}, {"Citation": "Pathania R., Ramachandran S., Mariappan G., Thakur P., Shi H., Choi J.-H., Manicassamy S., Kolhe R., Prasad P.D., Sharma S. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth. Cancer Res. 2016;76:3224\u20133235. doi: 10.1158/0008-5472.CAN-15-2249.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2249", "PMC4891240", "27197203"]}, {"Citation": "Li W., Ding X., Wang S., Xu L., Yin T., Han S., Geng J., Sun W. Downregulation of Serum Exosomal MiR-320d Predicts Poor Prognosis in Hepatocellular Carcinoma. J. Clin. Lab. Anal. 2020;34:e23239. doi: 10.1002/jcla.23239.", "ArticleIdList": ["10.1002/jcla.23239", "PMC7307335", "32125733"]}, {"Citation": "Byles V., Zhu L., Lovaas J.D., Chmilewski L.K., Wang J., Faller D.V., Dai Y. SIRT1 Induces EMT by Cooperating with EMT Transcription Factors and Enhances Prostate Cancer Cell Migration and Metastasis. Oncogene. 2012;31:4619\u20134629. doi: 10.1038/onc.2011.612.", "ArticleIdList": ["10.1038/onc.2011.612", "PMC4157820", "22249256"]}, {"Citation": "Cheng X., Hung M.-C. Breast Cancer Brain Metastases. Cancer Metastasis Rev. 2007;26:635\u2013643. doi: 10.1007/s10555-007-9083-x.", "ArticleIdList": ["10.1007/s10555-007-9083-x", "17717635"]}, {"Citation": "Zhou J., Li W., Guo J., Li G., Chen F., Zhou J. Downregulation of MiR-329 Promotes Cell Invasion by Regulating BRD4 and Predicts Poor Prognosis in Hepatocellular Carcinoma. Tumor Biol. 2016;37:3561\u20133569. doi: 10.1007/s13277-015-4109-4.", "ArticleIdList": ["10.1007/s13277-015-4109-4", "26456956"]}, {"Citation": "Ma X., Ezzeldin H.H., Diasio R.B. Histone Deacetylase Inhibitors. Drugs. 2009;69:1911\u20131934. doi: 10.2165/11315680-000000000-00000.", "ArticleIdList": ["10.2165/11315680-000000000-00000", "19747008"]}, {"Citation": "Lee J.-Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.-P. Disease-Causing Mutations in Parkin Impair Mitochondrial Ubiquitination, Aggregation, and HDAC6-Dependent Mitophagy. J. Cell Biol. 2010;189:671\u2013679. doi: 10.1083/jcb.201001039.", "ArticleIdList": ["10.1083/jcb.201001039", "PMC2872903", "20457763"]}, {"Citation": "Peinado H., Olmeda D., Cano A. Snail, Zeb and BHLH Factors in Tumour Progression: An Alliance against the Epithelial Phenotype? Nat. Rev. Cancer. 2007;7:415\u2013428. doi: 10.1038/nrc2131.", "ArticleIdList": ["10.1038/nrc2131", "17508028"]}, {"Citation": "Von Burstin J., Eser S., Paul M.C., Seidler B., Brandl M., Messer M., von Werder A., Schmidt A., Mages J., Pagel P. E-Cadherin Regulates Metastasis of Pancreatic Cancer in Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex. Gastroenterology. 2009;137:361\u2013371. doi: 10.1053/j.gastro.2009.04.004.", "ArticleIdList": ["10.1053/j.gastro.2009.04.004", "19362090"]}, {"Citation": "Carmeliet P. Angiogenesis in Life, Disease and Medicine. Nature. 2005;438:932\u2013936. doi: 10.1038/nature04478.", "ArticleIdList": ["10.1038/nature04478", "16355210"]}, {"Citation": "Moehler T., Neben K., Ho A., Goldschmidt H. Angiogenesis in Hematologic Malignancies. Ann. Hematol. 2001;80:695\u2013705. doi: 10.1007/s00277-001-0398-3.", "ArticleIdList": ["10.1007/s00277-001-0398-3", "11797109"]}, {"Citation": "Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.-E., Lee S.-W., Moon E.-J., Kim H.-S., Lee S.-K., Chung H.Y. Histone Deacetylases Induce Angiogenesis by Negative Regulation of Tumor Suppressor Genes. Nat. Med. 2001;7:437\u2013443. doi: 10.1038/86507.", "ArticleIdList": ["10.1038/86507", "11283670"]}, {"Citation": "Hrgovic I., Doll M., Pinter A., Kaufmann R., Kippenberger S., Meissner M. Histone Deacetylase Inhibitors Interfere with Angiogenesis by Decreasing Endothelial VEGFR-2 Protein Half-Life in Part via a VE-Cadherin-Dependent Mechanism. Exp. Dermatol. 2017;26:194\u2013201. doi: 10.1111/exd.13159.", "ArticleIdList": ["10.1111/exd.13159", "27487811"]}, {"Citation": "Schoepflin Z.R., Shapiro I.M., Risbud M.V. Class I and IIa HDACs Mediate HIF-1\u03b1 Stability Through PHD2-Dependent Mechanism, While HDAC6, a Class IIb Member, Promotes HIF-1\u03b1 Transcriptional Activity in Nucleus Pulposus Cells of the Intervertebral Disc. J. Bone Miner. Res. 2016;31:1287\u20131299. doi: 10.1002/jbmr.2787.", "ArticleIdList": ["10.1002/jbmr.2787", "PMC4891304", "26765925"]}, {"Citation": "Urbich C., R\u00f6ssig L., Kaluza D., Potente M., Boeckel J.-N., Knau A., Diehl F., Geng J.-G., Hofmann W.-K., Zeiher A.M. HDAC5 Is a Repressor of Angiogenesis and Determines the Angiogenic Gene Expression Pattern of Endothelial Cells. Blood J. Am. Soc. Hematol. 2009;113:5669\u20135679. doi: 10.1182/blood-2009-01-196485.", "ArticleIdList": ["10.1182/blood-2009-01-196485", "19351956"]}, {"Citation": "Tsou P.-S., Khanna D., Sawalha A.H. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma. Arthritis Rheumatol. 2019;71:1350\u20131359. doi: 10.1002/art.40890.", "ArticleIdList": ["10.1002/art.40890", "PMC6663606", "30884213"]}, {"Citation": "Kaluza D., Kroll J., Gesierich S., Yao T.-P., Boon R.A., Hergenreider E., Tjwa M., R\u00f6ssig L., Seto E., Augustin H.G. Class IIb HDAC6 Regulates Endothelial Cell Migration and Angiogenesis by Deacetylation of Cortactin. EMBO J. 2011;30:4142\u20134156. doi: 10.1038/emboj.2011.298.", "ArticleIdList": ["10.1038/emboj.2011.298", "PMC3199386", "21847094"]}, {"Citation": "Cecconi F., Levine B. The Role of Autophagy in Mammalian Development: Cell Makeover Rather than Cell Death. Dev. Cell. 2008;15:344\u2013357. doi: 10.1016/j.devcel.2008.08.012.", "ArticleIdList": ["10.1016/j.devcel.2008.08.012", "PMC2688784", "18804433"]}, {"Citation": "Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., G\u00e9linas C., Fan Y. Autophagy Promotes Tumor Cell Survival and Restricts Necrosis, Inflammation, and Tumorigenesis. Cancer Cell. 2006;10:51\u201364. doi: 10.1016/j.ccr.2006.06.001.", "ArticleIdList": ["10.1016/j.ccr.2006.06.001", "PMC2857533", "16843265"]}, {"Citation": "Moresi V., Carrer M., Grueter C.E., Rifki O.F., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. Histone Deacetylases 1 and 2 Regulate Autophagy Flux and Skeletal Muscle Homeostasis in Mice. Proc. Natl. Acad. Sci. USA. 2012;109:1649\u20131654. doi: 10.1073/pnas.1121159109.", "ArticleIdList": ["10.1073/pnas.1121159109", "PMC3277131", "22307625"]}, {"Citation": "Majora M., Sondenheimer K., Knechten M., Uthe I., Esser C., Schiavi A., Ventura N., Krutmann J. HDAC Inhibition Improves Autophagic and Lysosomal Function to Prevent Loss of Subcutaneous Fat in a Mouse Model of Cockayne Syndrome. Sci. Transl. Med. 2018;10:eaam7510. doi: 10.1126/scitranslmed.aam7510.", "ArticleIdList": ["10.1126/scitranslmed.aam7510", "30158153"]}, {"Citation": "Yang X.-J., Seto E. The Rpd3/Hda1 Family of Lysine Deacetylases: From Bacteria and Yeast to Mice and Men. Nat. Rev. Mol. Cell Biol. 2008;9:206\u2013218. doi: 10.1038/nrm2346.", "ArticleIdList": ["10.1038/nrm2346", "PMC2667380", "18292778"]}, {"Citation": "Lee K.J., Lee K.Y., Lee Y.M. Downregulation of a Tumor Suppressor RECK by Hypoxia through Recruitment of HDAC1 and HIF-1\u03b1 to Reverse HRE Site in the Promoter. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2010;1803:608\u2013616. doi: 10.1016/j.bbamcr.2010.01.004.", "ArticleIdList": ["10.1016/j.bbamcr.2010.01.004", "20080132"]}, {"Citation": "Oehme I., Linke J.-P., B\u00f6ck B.C., Milde T., Lodrini M., Hartenstein B., Wiegand I., Eckert C., Roth W., Kool M. Histone Deacetylase 10 Promotes Autophagy-Mediated Cell Survival. Proc. Natl. Acad. Sci. USA. 2013;110:E2592\u2013E2601. doi: 10.1073/pnas.1300113110.", "ArticleIdList": ["10.1073/pnas.1300113110", "PMC3710791", "23801752"]}, {"Citation": "Garva R., Thepmalee C., Yasamut U., Sudsaward S., Guazzelli A., Rajendran R., Tongmuang N., Khunchai S., Meysami P., Limjindaporn T. Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress. Front. Oncol. 2019;9:949. doi: 10.3389/fonc.2019.00949.", "ArticleIdList": ["10.3389/fonc.2019.00949", "PMC6771295", "31608237"]}, {"Citation": "Huang R., Xu Y., Wan W., Shou X., Qian J., You Z., Liu B., Chang C., Zhou T., Lippincott-Schwartz J. Deacetylation of Nuclear LC3 Drives Autophagy Initiation under Starvation. Mol. Cell. 2015;57:456\u2013466. doi: 10.1016/j.molcel.2014.12.013.", "ArticleIdList": ["10.1016/j.molcel.2014.12.013", "25601754"]}, {"Citation": "Ou X., Lee M.R., Huang X., Messina-Graham S., Broxmeyer H.E. SIRT1 Positively Regulates Autophagy and Mitochondria Function in Embryonic Stem Cells under Oxidative Stress. Stem Cells. 2014;32:1183\u20131194. doi: 10.1002/stem.1641.", "ArticleIdList": ["10.1002/stem.1641", "PMC3991763", "24449278"]}, {"Citation": "Polletta L., Vernucci E., Carnevale I., Arcangeli T., Rotili D., Palmerio S., Steegborn C., Nowak T., Schutkowski M., Pellegrini L. SIRT5 Regulation of Ammonia-Induced Autophagy and Mitophagy. Autophagy. 2015;11:253\u2013270. doi: 10.1080/15548627.2015.1009778.", "ArticleIdList": ["10.1080/15548627.2015.1009778", "PMC4502726", "25700560"]}, {"Citation": "Shi L., Yan H., An S., Shen M., Jia W., Zhang R., Zhao L., Huang G., Liu J. SIRT 5-Mediated Deacetylation of LDHB Promotes Autophagy and Tumorigenesis in Colorectal Cancer. Mol. Oncol. 2019;13:358\u2013375. doi: 10.1002/1878-0261.12408.", "ArticleIdList": ["10.1002/1878-0261.12408", "PMC6360364", "30443978"]}, {"Citation": "Guo J., Wang Z., Wu J., Liu M., Li M., Sun Y., Huang W., Li Y., Zhang Y., Tang W. Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury through Targeting Nkx3. 2-GATA5 Signaling. Circ. Res. 2019;124:1448\u20131461. doi: 10.1161/CIRCRESAHA.118.314032.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.314032", "30894089"]}, {"Citation": "Moseley V.R., Morris J., Knackstedt R.W., Wargovich M.J. Green Tea Polyphenol Epigallocatechin 3-Gallate, Contributes to the Degradation of DNMT3A and HDAC3 in HCT 116 Human Colon Cancer Cells. Anticancer. Res. 2013;33:5325\u20135333.", "ArticleIdList": ["PMC4017340", "24324066"]}, {"Citation": "Groh I.A.M., Chen C., L\u00fcske C., Cartus A.T., Esselen M. Plant Polyphenols and Oxidative Metabolites of the Herbal Alkenylbenzene Methyleugenol Suppress Histone Deacetylase Activity in Human Colon Carcinoma Cells. J. Nutr. Metab. 2013;2013:821082. doi: 10.1155/2013/821082.", "ArticleIdList": ["10.1155/2013/821082", "PMC3583079", "23476753"]}, {"Citation": "Meeran S.M., Patel S.N., Chan T.-H., Tollefsbol T.O. A Novel Prodrug of Epigallocatechin-3-Gallate: Differential Epigenetic HTERT Repression in Human Breast Cancer Cells. Cancer Prev. Res. 2011;4:1243\u20131254. doi: 10.1158/1940-6207.CAPR-11-0009.", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0009", "PMC3128170", "21411498"]}, {"Citation": "Nandakumar V., Vaid M., Katiyar S.K. (\u2212)-Epigallocatechin-3-Gallate Reactivates Silenced Tumor Suppressor Genes, Cip1/P21 and P16INK4a, by Reducing DNA Methylation and Increasing Histones Acetylation in Human Skin Cancer Cells. Carcinogenesis. 2011;32:537\u2013544. doi: 10.1093/carcin/bgq285.", "ArticleIdList": ["10.1093/carcin/bgq285", "PMC3066414", "21209038"]}, {"Citation": "Ciesielski O., Biesiekierska M., Balcerczyk A. Epigallocatechin-3-Gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells. Molecules. 2020;25:2326. doi: 10.3390/molecules25102326.", "ArticleIdList": ["10.3390/molecules25102326", "PMC7287656", "32429384"]}, {"Citation": "Pandey M., Kaur P., Shukla S., Abbas A., Fu P., Gupta S. Plant Flavone Apigenin Inhibits HDAC and Remodels Chromatin to Induce Growth Arrest and Apoptosis in Human Prostate Cancer Cells: In Vitro and in Vivo Study. Mol. Carcinog. 2012;51:952\u2013962. doi: 10.1002/mc.20866.", "ArticleIdList": ["10.1002/mc.20866", "PMC4019962", "22006862"]}, {"Citation": "Tseng T.-H., Chien M.-H., Lin W.-L., Wen Y.-C., Chow J.-M., Chen C.-K., Kuo T.-C., Lee W.-J. Inhibition of MDA-MB-231 Breast Cancer Cell Proliferation and Tumor Growth by Apigenin through Induction of G2/M Arrest and Histone H3 Acetylation-Mediated P21 WAF1/CIP1 Expression: APIGENIN INHIBITS MDA-MB-231 BREAST CANCER CELL. Environ. Toxicol. 2017;32:434\u2013444. doi: 10.1002/tox.22247.", "ArticleIdList": ["10.1002/tox.22247", "26872304"]}, {"Citation": "Zeng H., Huang P., Wang X., Wu J., Wu M., Huang J. Galangin-Induced down-Regulation of BACE1 by Epigenetic Mechanisms in SH-SY5Y Cells. Neuroscience. 2015;294:172\u2013181. doi: 10.1016/j.neuroscience.2015.02.054.", "ArticleIdList": ["10.1016/j.neuroscience.2015.02.054", "25779965"]}, {"Citation": "Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., Yang C.S. Reversal of Hypermethylation and Reactivation of P16INK4a, RAR\u03b2, and MGMT Genes by Genistein and Other Isoflavones from Soy. Clin. Cancer Res. 2005;11:7033\u20137041. doi: 10.1158/1078-0432.CCR-05-0406.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-0406", "16203797"]}, {"Citation": "Majid S., Dar A.A., Shahryari V., Hirata H., Ahmad A., Saini S., Tanaka Y., Dahiya A.V., Dahiya R. Genistein Reverses Hypermethylation and Induces Active Histone Modifications in Tumor Suppressor Gene B-Cell Translocation Gene 3 in Prostate Cancer. Cancer. 2009;116:66\u201376. doi: 10.1002/cncr.24662.", "ArticleIdList": ["10.1002/cncr.24662", "PMC3954042", "19885928"]}, {"Citation": "Li Y., Meeran S.M., Patel S.N., Chen H., Hardy T.M., Tollefsbol T.O. Epigenetic Reactivation of Estrogen Receptor-\u03b1 (ER\u03b1) by Genistein Enhances Hormonal Therapy Sensitivity in ER\u03b1-Negative Breast Cancer. Mol. Cancer. 2013;12:9. doi: 10.1186/1476-4598-12-9.", "ArticleIdList": ["10.1186/1476-4598-12-9", "PMC3577460", "23379261"]}, {"Citation": "Zhang Y., Li Q., Chen H. DNA Methylation and Histone Modifications of Wnt Genes by Genistein during Colon Cancer Development. Carcinogenesis. 2013;34:1756\u20131763. doi: 10.1093/carcin/bgt129.", "ArticleIdList": ["10.1093/carcin/bgt129", "PMC3731807", "23598468"]}, {"Citation": "Mateen S., Tyagi A., Agarwal C., Singh R.P., Agarwal R. Silibinin Inhibits Human Nonsmall Cell Lung Cancer Cell Growth through Cell-Cycle Arrest by Modulating Expression and Function of Key Cell-Cycle Regulators. Mol. Carcinog. 2010;49:247\u2013258. doi: 10.1002/mc.20595.", "ArticleIdList": ["10.1002/mc.20595", "PMC3049548", "19908243"]}, {"Citation": "Anestopoulos I., Sfakianos A., Franco R., Chlichlia K., Panayiotidis M., Kroll D., Pappa A. A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma. Molecules. 2016;22:62. doi: 10.3390/molecules22010062.", "ArticleIdList": ["10.3390/molecules22010062", "PMC6155798", "28042859"]}, {"Citation": "Berger A., Venturelli S., Kallnischkies M., B\u00f6cker A., Busch C., Weiland T., Noor S., Leischner C., Weiss T.S., Lauer U.M., et al. Kaempferol, a New Nutrition-Derived Pan-Inhibitor of Human Histone Deacetylases. J. Nutr. Biochem. 2013;24:977\u2013985. doi: 10.1016/j.jnutbio.2012.07.001.", "ArticleIdList": ["10.1016/j.jnutbio.2012.07.001", "23159065"]}, {"Citation": "Lee W.-J., Chen Y.-R., Tseng T.-H. Quercetin Induces FasL-Related Apoptosis, in Part, through Promotion of Histone H3 Acetylation in Human Leukemia HL-60 Cells. Oncol. Rep. 2011;25:583\u2013591.", "ArticleIdList": ["21165570"]}, {"Citation": "Kedhari Sundaram M., Hussain A., Haque S., Raina R., Afroze N. Quercetin Modifies 5\u2032CpG Promoter Methylation and Reactivates Various Tumor Suppressor Genes by Modulating Epigenetic Marks in Human Cervical Cancer Cells. J. Cell. Biochem. 2019;120:18357\u201318369. doi: 10.1002/jcb.29147.", "ArticleIdList": ["10.1002/jcb.29147", "31172592"]}, {"Citation": "Mirza S., Sharma G., Parshad R., Gupta S.D., Pandya P., Ralhan R. Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins. J. Breast Cancer. 2013;16:23\u201331. doi: 10.4048/jbc.2013.16.1.23.", "ArticleIdList": ["10.4048/jbc.2013.16.1.23", "PMC3625766", "23593078"]}, {"Citation": "Deb G., Thakur V.S., Limaye A.M., Gupta S. Epigenetic Induction of Tissue Inhibitor of Matrix Metalloproteinase-3 by Green Tea Polyphenols in Breast Cancer Cells. Mol. Carcinog. 2015;54:485\u2013499. doi: 10.1002/mc.22121.", "ArticleIdList": ["10.1002/mc.22121", "24481780"]}, {"Citation": "Saldanha S.N., Kala R., Tollefsbol T.O. Molecular Mechanisms for Inhibition of Colon Cancer Cells by Combined Epigenetic-Modulating Epigallocatechin Gallate and Sodium Butyrate. Exp. Cell Res. 2014;324:40\u201353. doi: 10.1016/j.yexcr.2014.01.024.", "ArticleIdList": ["10.1016/j.yexcr.2014.01.024", "PMC4043227", "24518414"]}, {"Citation": "Khan M.A., Hussain A., Sundaram M.K., Alalami U., Gunasekera D., Ramesh L., Hamza A., Quraishi U. (\u2212)-Epigallocatechin-3-Gallate Reverses the Expression of Various Tumor-Suppressor Genes by Inhibiting DNA Methyltransferases and Histone Deacetylases in Human Cervical Cancer Cells. Oncol. Rep. 2015;33:1976\u20131984. doi: 10.3892/or.2015.3802.", "ArticleIdList": ["10.3892/or.2015.3802", "25682960"]}, {"Citation": "Zhang Y., Wang X., Han L., Zhou Y., Sun S. Green Tea Polyphenol EGCG Reverse Cisplatin Resistance of A549/DDP Cell Line through Candidate Genes Demethylation. Biomed. Pharmacother. 2015;69:285\u2013290. doi: 10.1016/j.biopha.2014.12.016.", "ArticleIdList": ["10.1016/j.biopha.2014.12.016", "25661371"]}, {"Citation": "Borutinskait\u0117 V., Virk\u0161ait\u0117 A., Gudelyt\u0117 G., Navakauskien\u0117 R. Green Tea Polyphenol EGCG Causes Anti-Cancerous Epigenetic Modulations in Acute Promyelocytic Leukemia Cells. Leuk. Lymphoma. 2018;59:469\u2013478. doi: 10.1080/10428194.2017.1339881.", "ArticleIdList": ["10.1080/10428194.2017.1339881", "28641467"]}, {"Citation": "Deb G., Shankar E., Thakur V.S., Ponsky L.E., Bodner D.R., Fu P., Gupta S. Green Tea-Induced Epigenetic Reactivation of Tissue Inhibitor of Matrix Metalloproteinase-3 Suppresses Prostate Cancer Progression through Histone-Modifying Enzymes. Mol. Carcinog. 2019;58:1194\u20131207. doi: 10.1002/mc.23003.", "ArticleIdList": ["10.1002/mc.23003", "30854739"]}, {"Citation": "Steed K.L., Jordan H.R., Tollefsbol T.O. SAHA and EGCG Promote Apoptosis in Triple-Negative Breast Cancer Cells, Possibly Through the Modulation of CIAP2. Anticancer Res. 2020;40:9\u201326. doi: 10.21873/anticanres.13922.", "ArticleIdList": ["10.21873/anticanres.13922", "PMC7032656", "31892549"]}, {"Citation": "Kuo H.-C.D., Wu R., Li S., Yang A.Y., Kong A.-N. Anthocyanin Delphinidin Prevents Neoplastic Transformation of Mouse Skin JB6 P+ Cells: Epigenetic Re-Activation of Nrf2-ARE Pathway. AAPS J. 2019;21:83. doi: 10.1208/s12248-019-0355-5.", "ArticleIdList": ["10.1208/s12248-019-0355-5", "PMC6669902", "31254216"]}, {"Citation": "Paredes-Gonzalez X., Fuentes F., Su Z.-Y., Kong A.-N.T. Apigenin Reactivates Nrf2 Anti-Oxidative Stress Signaling in Mouse Skin Epidermal JB6 P + Cells Through Epigenetics Modifications. AAPS J. 2014;16:727\u2013735. doi: 10.1208/s12248-014-9613-8.", "ArticleIdList": ["10.1208/s12248-014-9613-8", "PMC4070251", "24830944"]}, {"Citation": "Paul B., Li Y., Tollefsbol T. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation. Int. J. Mol. Sci. 2018;19:1754. doi: 10.3390/ijms19061754.", "ArticleIdList": ["10.3390/ijms19061754", "PMC6032337", "29899271"]}, {"Citation": "Sundaram M., Mz A., Aa M. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells. Anticancer Agents Med. Chem. 2018;18:412\u2013421. doi: 10.2174/1871520617666170918142114.", "ArticleIdList": ["10.2174/1871520617666170918142114", "28925878"]}, {"Citation": "Attoub S., Hassan A.H., Vanhoecke B., Iratni R., Takahashi T., Gaben A.-M., Bracke M., Awad S., John A., Kamalboor H.A., et al. Inhibition of Cell Survival, Invasion, Tumor Growth and Histone Deacetylase Activity by the Dietary Flavonoid Luteolin in Human Epithelioid Cancer Cells. Eur. J. Pharmacol. 2011;651:18\u201325. doi: 10.1016/j.ejphar.2010.10.063.", "ArticleIdList": ["10.1016/j.ejphar.2010.10.063", "21074525"]}, {"Citation": "Zuo Q., Wu R., Xiao X., Yang C., Yang Y., Wang C., Lin L., Kong A. The Dietary Flavone Luteolin Epigenetically Activates the Nrf2 Pathway and Blocks Cell Transformation in Human Colorectal Cancer HCT116 Cells. J. Cell. Biochem. 2018;119:9573\u20139582. doi: 10.1002/jcb.27275.", "ArticleIdList": ["10.1002/jcb.27275", "PMC6195448", "30129150"]}, {"Citation": "Zhang T., Li S., Li J., Yin F., Hua Y., Wang Z., Lin B., Wang H., Zou D., Zhou Z., et al. Natural Product Pectolinarigenin Inhibits Osteosarcoma Growth and Metastasis via SHP-1-Mediated STAT3 Signaling Inhibition. Cell Death Dis. 2016;7:e2421. doi: 10.1038/cddis.2016.305.", "ArticleIdList": ["10.1038/cddis.2016.305", "PMC5133974", "27735939"]}, {"Citation": "Li S., Li W., Wang C., Wu R., Yin R., Kuo H.-C., Wang L., Kong A.-N. Pelargonidin Reduces the TPA Induced Transformation of Mouse Epidermal Cells \u2013Potential Involvement of Nrf2 Promoter Demethylation. Chem. Biol. Interact. 2019;309:108701. doi: 10.1016/j.cbi.2019.06.014.", "ArticleIdList": ["10.1016/j.cbi.2019.06.014", "PMC6679730", "31181187"]}, {"Citation": "Kauntz H., Bousserouel S., Goss\u00e9 F., Raul F. Epigenetic Effects of the Natural Flavonolignan Silibinin on Colon Adenocarcinoma Cells and Their Derived Metastatic Cells. Oncol. Lett. 2013;5:1273\u20131277. doi: 10.3892/ol.2013.1190.", "ArticleIdList": ["10.3892/ol.2013.1190", "PMC3629096", "23599778"]}, {"Citation": "Kuang H., Tang Z., Zhang C., Wang Z., Li W., Yang C., Wang Q., Yang B., Kong A.-N. Taxifolin Activates the Nrf2 Anti-Oxidative Stress Pathway in Mouse Skin Epidermal JB6 P+ Cells through Epigenetic Modifications. Int. J. Mol. Sci. 2017;18:1546. doi: 10.3390/ijms18071546.", "ArticleIdList": ["10.3390/ijms18071546", "PMC5536034", "28714938"]}, {"Citation": "Priyadarsini R.V., Vinothini G., Murugan R.S., Manikandan P., Nagini S. The Flavonoid Quercetin Modulates the Hallmark Capabilities of Hamster Buccal Pouch Tumors. Nutr. Cancer. 2011;63:218\u2013226. doi: 10.1080/01635581.2011.523503.", "ArticleIdList": ["10.1080/01635581.2011.523503", "21294050"]}, {"Citation": "Zheng N.-G., Wang J.-L., Yang S.-L., Wu J.-L. Aberrant Epigenetic Alteration in Eca9706 Cells Modulated by Nanoliposomal Quercetin Combined with Butyrate Mediated via Epigenetic-NF-\u039aB Signaling. Asian Pac. J. Cancer Prev. 2014;15:4539\u20134543. doi: 10.7314/APJCP.2014.15.11.4539.", "ArticleIdList": ["10.7314/APJCP.2014.15.11.4539", "24969881"]}, {"Citation": "Wang Z., Liu Y., Xue Y., Hu H., Ye J., Li X., Lu Z., Meng F., Liang S. Berberine Acts as a Putative Epigenetic Modulator by Affecting the Histone Code. Toxicol. Vitr. 2016;36:10\u201317. doi: 10.1016/j.tiv.2016.06.004.", "ArticleIdList": ["10.1016/j.tiv.2016.06.004", "27311644"]}, {"Citation": "Florean C., Schnekenburger M., Lee J.-Y., Kim K.R., Mazumder A., Song S., Kim J.-M., Grandjenette C., Kim J.-G., Yoon A.-Y., et al. Discovery and Characterization of Isofistularin-3, a Marine Brominated Alkaloid, as a New DNA Demethylating Agent Inducing Cell Cycle Arrest and Sensitization to TRAIL in Cancer Cells. Oncotarget. 2016;7:24027\u201324049. doi: 10.18632/oncotarget.8210.", "ArticleIdList": ["10.18632/oncotarget.8210", "PMC5029682", "27006469"]}, {"Citation": "Tiwari P., Gupta K.P. Modulation of MiR-203 and Its Regulators as a Function of Time during the Development of 7, 12 Dimethylbenz [a] Anthracene Induced Mouse Skin Tumors in Presence or Absence of the Antitumor Agents. Toxicol. Appl. Pharmacol. 2014;278:148\u2013158. doi: 10.1016/j.taap.2014.04.020.", "ArticleIdList": ["10.1016/j.taap.2014.04.020", "24792773"]}, {"Citation": "Vincent A., Ducourouble M., Van Seuningen I. Epigenetic Regulation of the Human Mucin Gene MUC4 in Epithelial Cancer Cell Lines Involves Both DNA Methylation and Histone Modifications Mediated by DNA Methyltransferases and Histone Deacetylases. FASEB J. 2008;22:3035\u20133045. doi: 10.1096/fj.07-103390.", "ArticleIdList": ["10.1096/fj.07-103390", "18492726"]}, {"Citation": "Ahn M.Y., Jung J.H., Na Y.J., Kim H.S. A Natural Histone Deacetylase Inhibitor, Psammaplin A, Induces Cell Cycle Arrest and Apoptosis in Human Endometrial Cancer Cells. Gynecol. Oncol. 2008;108:27\u201333. doi: 10.1016/j.ygyno.2007.08.098.", "ArticleIdList": ["10.1016/j.ygyno.2007.08.098", "17920664"]}, {"Citation": "Baud M.G.J., Leiser T., Haus P., Samlal S., Wong A.C., Wood R.J., Petrucci V., Gunaratnam M., Hughes S.M., Buluwela L., et al. Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets. J. Med. Chem. 2012;55:1731\u20131750. doi: 10.1021/jm2016182.", "ArticleIdList": ["10.1021/jm2016182", "22280363"]}, {"Citation": "Pi\u00f1a I.C., Gautschi J.T., Wang G.-Y.-S., Sanders M.L., Schmitz F.J., France D., Cornell-Kennon S., Sambucetti L.C., Remiszewski S.W., Perez L.B., et al. Psammaplins from the Sponge Pseudoceratina p Urpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase. J. Org. Chem. 2003;68:3866\u20133873. doi: 10.1021/jo034248t.", "ArticleIdList": ["10.1021/jo034248t", "12737565"]}, {"Citation": "Meng F., Sun G., Zhong M., Yu Y., Brewer M.A. Inhibition of DNA Methyltransferases, Histone Deacetylases and Lysine-Specific Demethylase-1 Suppresses the Tumorigenicity of the Ovarian Cancer Ascites Cell Line SKOV3. Int. J. Oncol. 2013;43:495\u2013502. doi: 10.3892/ijo.2013.1960.", "ArticleIdList": ["10.3892/ijo.2013.1960", "23709006"]}, {"Citation": "Zhang C., Wang C., Li W., Wu R., Guo Y., Cheng D., Yang Y., Androulakis I.P., Kong A.-N. Pharmacokinetics and Pharmacodynamics of the Triterpenoid Ursolic Acid in Regulating the Antioxidant, Anti-Inflammatory, and Epigenetic Gene Responses in Rat Leukocytes. Mol. Pharm. 2017;14:3709\u20133717. doi: 10.1021/acs.molpharmaceut.7b00469.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00469", "PMC5697757", "29035547"]}, {"Citation": "Shukla S., Khan S., Kumar S., Sinha S., Farhan M., Bora H.K., Maurya R., Meeran S.M. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis. Cancer Prev. Res. 2015;8:552\u2013562. doi: 10.1158/1940-6207.CAPR-14-0286.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0286", "25813524"]}, {"Citation": "Machado D.G., Neis V.B., Balen G.O., Colla A., Cunha M.P., Dalmarco J.B., Pizzolatti M.G., Prediger R.D., Rodrigues A.L.S. Antidepressant-like Effect of Ursolic Acid Isolated from Rosmarinus officinalis L. in Mice: Evidence for the Involvement of the Dopaminergic System. Pharmacol. Biochem. Behav. 2012;103:204\u2013211. doi: 10.1016/j.pbb.2012.08.016.", "ArticleIdList": ["10.1016/j.pbb.2012.08.016", "22940588"]}, {"Citation": "Kondo M., MacKinnon S.L., Craft C.C., Matchett M.D., Hurta R.A., Neto C.C. Ursolic Acid and Its Esters: Occurrence in Cranberries and Other Vaccinium Fruit and Effects on Matrix Metalloproteinase Activity in DU145 Prostate Tumor Cells. J. Sci. Food Agric. 2011;91:789\u2013796. doi: 10.1002/jsfa.4330.", "ArticleIdList": ["10.1002/jsfa.4330", "21351105"]}, {"Citation": "Gopal Y.N.V., Arora T.S., Van Dyke M.W. Parthenolide Specifically Depletes Histone Deacetylase 1 Protein and Induces Cell Death through Ataxia Telangiectasia Mutated. Chem. Biol. 2007;14:813\u2013823. doi: 10.1016/j.chembiol.2007.06.007.", "ArticleIdList": ["10.1016/j.chembiol.2007.06.007", "17656318"]}, {"Citation": "Dai Y., Guzman M.L., Chen S., Wang L., Yeung S.-K., Pei X.-Y., Dent P., Jordan C.T., Grant S. The NF (Nuclear Factor)-\u039aB Inhibitor Parthenolide Interacts with Histone Deacetylase Inhibitors to Induce MKK7/JNK1-Dependent Apoptosis in Human Acute Myeloid Leukaemia Cells: Parthenolide Potentiates HDAC Inhibitor Lethality in AML. Br. J. Haematol. 2010;151:70\u201383. doi: 10.1111/j.1365-2141.2010.08319.x.", "ArticleIdList": ["10.1111/j.1365-2141.2010.08319.x", "PMC2950247", "20701602"]}, {"Citation": "Ghantous A., Saikali M., Rau T., Gali-Muhtasib H., Schneider-Stock R., Darwiche N. Inhibition of Tumor Promotion by Parthenolide: Epigenetic Modulation of P21. Cancer Prev. Res. 2012;5:1298\u20131309. doi: 10.1158/1940-6207.CAPR-12-0230.", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0230", "23037503"]}, {"Citation": "Carlisi D., Lauricella M., D\u2019Anneo A., Buttitta G., Emanuele S., di Fiore R., Martinez R., Rolfo C., Vento R., Tesoriere G. The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells: THE EFFECT OF PN/SAHA COMBINATION IN MDA-MB231 CELLS. J. Cell. Physiol. 2015;230:1276\u20131289. doi: 10.1002/jcp.24863.", "ArticleIdList": ["10.1002/jcp.24863", "25370819"]}, {"Citation": "Kim H., Ramirez C.N., Su Z.-Y., Kong A.-N.T. Epigenetic Modifications of Triterpenoid Ursolic Acid in Activating Nrf2 and Blocking Cellular Transformation of Mouse Epidermal Cells. J. Nutr. Biochem. 2016;33:54\u201362. doi: 10.1016/j.jnutbio.2015.09.014.", "ArticleIdList": ["10.1016/j.jnutbio.2015.09.014", "PMC4895202", "27260468"]}, {"Citation": "Ma H., Li L., Dou G., Wang C., Li J., He H., Wu M., Qi H. Z-Ligustilide Restores Tamoxifen Sensitivity of ER\u03b1 Negative Breast Cancer Cells by Reversing MTA1/IFI16/HDACs Complex Mediated Epigenetic Repression of ER\u03b1. Oncotarget. 2017;8:29328\u201329345. doi: 10.18632/oncotarget.16440.", "ArticleIdList": ["10.18632/oncotarget.16440", "PMC5438733", "28415616"]}, {"Citation": "Vital M., Gao J., Rizzo M., Harrison T., Tiedje J.M. Diet is a major factor governing the fecal butyrate-producing community structure across Mammalia, Aves and Reptilia. ISME J. 2015;9:832\u2013843. doi: 10.1038/ismej.2014.179.", "ArticleIdList": ["10.1038/ismej.2014.179", "PMC4817703", "25343515"]}, {"Citation": "Ceccarelli V., Ronchetti S., Marchetti M.C., Calvitti M., Riccardi C., Grignani F., Vecchini A. Molecular Mechanisms Underlying Eicosapentaenoic Acid Inhibition of HDAC1 and DNMT Expression and Activity in Carcinoma Cells. Biochim. Biophys. Acta (BBA) Gene Regul. Mech. 2020;1863:194481. doi: 10.1016/j.bbagrm.2020.194481.", "ArticleIdList": ["10.1016/j.bbagrm.2020.194481", "31923609"]}, {"Citation": "Park J.E., Sun Y., Lim S.K., Tam J.P., Dekker M., Chen H., Sze S.K. Dietary Phytochemical PEITC Restricts Tumor Development via Modulation of Epigenetic Writers and Erasers. Sci. Rep. 2017;7:40569. doi: 10.1038/srep40569.", "ArticleIdList": ["10.1038/srep40569", "PMC5228035", "28079155"]}, {"Citation": "Gupta R., Bhatt L.K., Momin M. Potent Antitumor Activity of Laccaic Acid and Phenethyl Isothiocyanate Combination in Colorectal Cancer via Dual Inhibition of DNA Methyltransferase-1 and Histone Deacetylase-1. Toxicol. Appl. Pharmacol. 2019;377:114631. doi: 10.1016/j.taap.2019.114631.", "ArticleIdList": ["10.1016/j.taap.2019.114631", "31228495"]}, {"Citation": "de Figueiredo S.M., Binda N.S., Nogueira-Machado J.A., Vieira-Filho S.A., Caligiorne R.B. The Antioxidant Properties of Organosulfur Compounds (Sulforaphane) Recent Pat. Endocr. Metab. Immune Drug Discov. 2015;9:24\u201339. doi: 10.2174/1872214809666150505164138.", "ArticleIdList": ["10.2174/1872214809666150505164138", "25944116"]}, {"Citation": "Meeran S.M., Patel S.N., Tollefsbol T.O. Sulforaphane Causes Epigenetic Repression of HTERT Expression in Human Breast Cancer Cell Lines. PLoS ONE. 2010;5:e11457. doi: 10.1371/journal.pone.0011457.", "ArticleIdList": ["10.1371/journal.pone.0011457", "PMC2897894", "20625516"]}, {"Citation": "Jiang L.-L., Zhou S.-J., Zhang X.-M., Chen H.-Q., Liu W. Sulforaphane Suppresses in Vitro and in Vivo Lung Tumorigenesis through Downregulation of HDAC Activity. Biomed. Pharmacother. 2016;78:74\u201380. doi: 10.1016/j.biopha.2015.11.007.", "ArticleIdList": ["10.1016/j.biopha.2015.11.007", "26898427"]}, {"Citation": "dos Santos P.W., Machado A.R.T., De Grandis R.A., Ribeiro D.L., Tuttis K., Morselli M., Aissa A.F., Pellegrini M., Antunes L.M.G. Transcriptome and DNA Methylation Changes Modulated by Sulforaphane Induce Cell Cycle Arrest, Apoptosis, DNA Damage, and Suppression of Proliferation in Human Liver Cancer Cells. Food Chem. Toxicol. 2020;136:111047. doi: 10.1016/j.fct.2019.111047.", "ArticleIdList": ["10.1016/j.fct.2019.111047", "31838189"]}, {"Citation": "Royston K., Udayakumar N., Lewis K., Tollefsbol T. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells. Int. J. Mol. Sci. 2017;18:1092. doi: 10.3390/ijms18051092.", "ArticleIdList": ["10.3390/ijms18051092", "PMC5455001", "28534825"]}, {"Citation": "Gao P., Jin J., Liu R., Jin Q., Wang X. Chemical Compositions of Walnut (Juglans regia L.) Oils from Different Cultivated Regions in China. J. Am. Oil Chem. Soc. 2018;95:825\u2013834. doi: 10.1002/aocs.12097.", "ArticleIdList": ["10.1002/aocs.12097"]}, {"Citation": "Li Y., Buckhaults P., Li S., Tollefsbol T. Temporal Efficacy of a Sulforaphane-Based Broccoli Sprout Diet in Prevention of Breast Cancer through Modulation of Epigenetic Mechanisms. Cancer Prev. Res. 2018;11:451\u2013464. doi: 10.1158/1940-6207.CAPR-17-0423.", "ArticleIdList": ["10.1158/1940-6207.CAPR-17-0423", "PMC6072582", "29764806"]}, {"Citation": "Martin S.L., Kala R., Tollefsbol T.O. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (HTERT) down-Regulation. Curr. Cancer Drug Targets. 2018;18:97\u2013106. doi: 10.2174/1568009617666170206104032.", "ArticleIdList": ["10.2174/1568009617666170206104032", "PMC5577390", "28176652"]}, {"Citation": "da Santos P.W. Master\u2019s Thesis. Universidade de S\u00e3o Paulo; S\u00e3o Paulo, Spain: 2019. Influ\u00eancia do Sulforafano, um Inibidor de Histonas Desacetilases, Sobre a Instabilidade gen\u00f4mica e Mecanismos Epigen\u00e9ticos em Linhagens Celulares Humanas. text."}, {"Citation": "Gupta A., Behl T., Panichayupakaranan P. A Review of Phytochemistry and Pharmacology Profile of Juglans Regia. Obes. Med. 2019;16:100142. doi: 10.1016/j.obmed.2019.100142.", "ArticleIdList": ["10.1016/j.obmed.2019.100142"]}, {"Citation": "Kim M.Y., Park S.-J., Shim J.W., Yang K., Kang H.S., Heo K. Naphthazarin Enhances Ionizing Radiation-Induced Cell Cycle Arrest and Apoptosis in Human Breast Cancer Cells. Int. J. Oncol. 2015;46:1659\u20131666. doi: 10.3892/ijo.2015.2857.", "ArticleIdList": ["10.3892/ijo.2015.2857", "25633658"]}, {"Citation": "Qadi S.A., Hassan M.A., Sheikh R.A., Baothman O.A., Zamzami M.A., Choudhry H., Al-Malki A.L., Albukhari A., Alhosin M. Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms. Genet. Epigenet. 2019;12:251686571983901. doi: 10.1177/2516865719839011.", "ArticleIdList": ["10.1177/2516865719839011", "PMC6452588", "31058255"]}, {"Citation": "Yang Y., Bae M., Kim B., Park Y.-K., Koo S.I., Lee J.-Y. Astaxanthin Prevents and Reverses the Activation of Mouse Primary Hepatic Stellate Cells. J. Nutr. Biochem. 2016;29:21\u201326. doi: 10.1016/j.jnutbio.2015.11.005.", "ArticleIdList": ["10.1016/j.jnutbio.2015.11.005", "26895661"]}, {"Citation": "Parashar G., Capalash N. Promoter Methylation-Independent Reactivation of PAX1 by Curcumin and Resveratrol Is Mediated by UHRF1. Clin. Exp. Med. 2016;16:471\u2013478. doi: 10.1007/s10238-015-0366-1.", "ArticleIdList": ["10.1007/s10238-015-0366-1", "26081871"]}, {"Citation": "Chen X., Li W., Xu C., Wang J., Zhu B., Huang Q., Chen D., Sheng J., Zou Y., Lee Y.M., et al. Comparative Profiling of Analog Targets: A Case Study on Resveratrol for Mouse Melanoma Metastasis Suppression. Theranostics. 2018;8:3504\u20133516. doi: 10.7150/thno.24336.", "ArticleIdList": ["10.7150/thno.24336", "PMC6037041", "30026862"]}, {"Citation": "Gao Y., Tollefsbol T. Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic\u2013Mediating Machinery. Int. J. Mol. Sci. 2018;19:2204. doi: 10.3390/ijms19082204.", "ArticleIdList": ["10.3390/ijms19082204", "PMC6121898", "30060527"]}, {"Citation": "Kang J., Chen J., Shi Y., Jia J., Zhang Y. Curcumin-Induced Histone Hypoacetylation: The Role of Reactive Oxygen Species. Biochem. Pharmacol. 2005;69:1205\u20131213. doi: 10.1016/j.bcp.2005.01.014.", "ArticleIdList": ["10.1016/j.bcp.2005.01.014", "15794941"]}, {"Citation": "Liu H., Chen Y., Cui G., Zhou J. Curcumin, a Potent Anti-Tumor Reagent, Is a Novel Histone Deacetylase Inhibitor Regulating B-NHL Cell Line Raji Proliferation. Acta Pharmacol. Sin. 2005;26:603\u2013609. doi: 10.1111/j.1745-7254.2005.00081.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00081.x", "15842781"]}, {"Citation": "Chen Y., Shu W., Chen W., Wu Q., Liu H., Cui G. Curcumin, Both Histone Deacetylase and P300/CBP-Specific Inhibitor, Represses the Activity of Nuclear Factor Kappa B and Notch 1 in Raji Cells. Basic Clin. Pharmacol. Toxicol. 2007;101:427\u2013433. doi: 10.1111/j.1742-7843.2007.00142.x.", "ArticleIdList": ["10.1111/j.1742-7843.2007.00142.x", "17927689"]}, {"Citation": "Bora-Tatar G., Dayanga\u00e7-Erden D., Demir A.S., Dalkara S., Yelek\u00e7i K., Erdem-Yurter H. Molecular Modifications on Carboxylic Acid Derivatives as Potent Histone Deacetylase Inhibitors: Activity and Docking Studies. Bioorganic Med. Chem. 2009;17:5219\u20135228. doi: 10.1016/j.bmc.2009.05.042.", "ArticleIdList": ["10.1016/j.bmc.2009.05.042", "19520580"]}, {"Citation": "Lee S.J., Krauthauser C., Maduskuie V., Fawcett P.T., Olson J.M., Rajasekaran S.A. Curcumin-Induced HDAC Inhibition and Attenuation of Medulloblastoma Growth in Vitro and in Vivo. BMC Cancer. 2011;11:144. doi: 10.1186/1471-2407-11-144.", "ArticleIdList": ["10.1186/1471-2407-11-144", "PMC3090367", "21501498"]}, {"Citation": "Shu L., Khor T.O., Lee J.-H., Boyanapalli S.S.S., Huang Y., Wu T.-Y., Saw C.L.-L., Cheung K.-L., Kong A.-N.T. Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells. AAPS J. 2011;13:606\u2013614. doi: 10.1208/s12248-011-9300-y.", "ArticleIdList": ["10.1208/s12248-011-9300-y", "PMC3231852", "21938566"]}, {"Citation": "Lee M.-J., Tsai Y.-J., Lin M.-Y., You H.-L., Kalyanam N., Ho C.-T., Pan M.-H. Calebin-A Induced Death of Malignant Peripheral Nerve Sheath Tumor Cells by Activation of Histone Acetyltransferase. Phytomedicine. 2019;57:377\u2013384. doi: 10.1016/j.phymed.2019.01.001.", "ArticleIdList": ["10.1016/j.phymed.2019.01.001", "30831486"]}, {"Citation": "Kala R., Shah H.N., Martin S.L., Tollefsbol T.O. Epigenetic-Based Combinatorial Resveratrol and Pterostilbene Alters DNA Damage Response by Affecting SIRT1 and DNMT Enzyme Expression, Including SIRT1-Dependent \u03b3-H2AX and Telomerase Regulation in Triple-Negative Breast Cancer. BMC Cancer. 2015;15:672. doi: 10.1186/s12885-015-1693-z.", "ArticleIdList": ["10.1186/s12885-015-1693-z", "PMC4603342", "26459286"]}, {"Citation": "Juli G., Oliverio M., Bellizzi D., Gallo Cantafio M.E., Grillone K., Passarino G., Colica C., Nardi M., Rossi M., Procopio A., et al. Anti-Tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma. Cancers. 2019;11:990. doi: 10.3390/cancers11070990.", "ArticleIdList": ["10.3390/cancers11070990", "PMC6679356", "31315220"]}, {"Citation": "Kang I., Okla M., Chung S. Ellagic Acid Inhibits Adipocyte Differentiation through Coactivator-Associated Arginine Methyltransferase 1-Mediated Chromatin Modification. J. Nutr. Biochem. 2014;25:946\u2013953. doi: 10.1016/j.jnutbio.2014.04.008.", "ArticleIdList": ["10.1016/j.jnutbio.2014.04.008", "24929439"]}, {"Citation": "Wang L., Zhang C., Guo Y., Su Z.-Y., Yang Y., Shu L., Kong A.-N.T. Blocking of JB6 Cell Transformation by Tanshinone IIA: Epigenetic Reactivation of Nrf2 Antioxidative Stress Pathway. AAPS J. 2014;16:1214\u20131225. doi: 10.1208/s12248-014-9666-8.", "ArticleIdList": ["10.1208/s12248-014-9666-8", "PMC4389756", "25274607"]}, {"Citation": "Liu D., Wu D., Zhao L., Yang Y., Ding J., Dong L., Hu L., Wang F., Zhao X., Cai Y., et al. Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase HMOF in Human Cells. PLoS ONE. 2015;10:e0141014. doi: 10.1371/journal.pone.0141014.", "ArticleIdList": ["10.1371/journal.pone.0141014", "PMC4608833", "26473953"]}, {"Citation": "Peng Z., Zhou W., Zhang C., Liu H., Zhang Y. Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation. Med. Sci. Monit. 2018;24:461\u2013472. doi: 10.12659/MSM.908430.", "ArticleIdList": ["10.12659/MSM.908430", "PMC5791388", "29363667"]}, {"Citation": "Xiang N., Zhao R., Song G., Zhong W. Selenium Modifies GSTP1 and Histone Methylation and Acetylation in Human Prostate Cancer Cells. AACR J. 2008;68:749."}, {"Citation": "Saiko P., Pemberger M., Horvath Z., Savinc I., Grusch M., Handler N., Erker T., Jaeger W., Fritzer-Szekeres M., Szekeres T. Novel Resveratrol Analogs Induce Apoptosis and Cause Cell Cycle Arrest in HT29 Human Colon Cancer Cells: Inhibition of Ribonucleotide Reductase Activity. Oncol. Rep. 2008;19:1621\u20131626.", "ArticleIdList": ["18497974"]}, {"Citation": "Koushki M., Amiri-Dashatan N., Ahmadi N., Abbaszadeh H.-A., Rezaei-Tavirani M. Resveratrol: A Miraculous Natural Compound for Diseases Treatment. Food Sci. Nutr. 2018;6:2473\u20132490. doi: 10.1002/fsn3.855.", "ArticleIdList": ["10.1002/fsn3.855", "PMC6261232", "30510749"]}, {"Citation": "Izquierdo-Torres E., Hern\u00e1ndez-Oliveras A., Meneses-Morales I., Rodr\u00edguez G., Fuentes-Garc\u00eda G., Zarain-Herzberg \u00c1. Resveratrol Up-Regulates ATP2A3 Gene Expression in Breast Cancer Cell Lines through Epigenetic Mechanisms. Int. J. Biochem. Cell Biol. 2019;113:37\u201347. doi: 10.1016/j.biocel.2019.05.020.", "ArticleIdList": ["10.1016/j.biocel.2019.05.020", "31173924"]}, {"Citation": "Aggarwal B.B., Yuan W., Li S., Gupta S.C. Curcumin-Free Turmeric Exhibits Anti-Inflammatory and Anticancer Activities: Identification of Novel Components of Turmeric. Mol. Nutr. Food Res. 2013;57:1529\u20131542. doi: 10.1002/mnfr.201200838.", "ArticleIdList": ["10.1002/mnfr.201200838", "23847105"]}, {"Citation": "Kala R., Tollefsbol T.O., Li Y. Potential of Resveratrol in Inhibiting Cancer and Slowing Aging. J. Nutr. Food Sci. S. 2012;5 doi: 10.4172/2155-9600.S5-001.", "ArticleIdList": ["10.4172/2155-9600.S5-001"]}, {"Citation": "Liu T., Liu P.Y., Marshall G.M. The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer. Cancer Res. 2009;69:1702\u20131705. doi: 10.1158/0008-5472.CAN-08-3365.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-3365", "19244112"]}, {"Citation": "Emadi A., Gore S.D. Arsenic trioxide\u2014An old drug rediscovered. Blood Rev. 2010;24:191\u2013199. doi: 10.1016/j.blre.2010.04.001.", "ArticleIdList": ["10.1016/j.blre.2010.04.001", "PMC2918685", "20471733"]}, {"Citation": "Hashem S., Nisar S., Sageena G., Macha M.A., Yadav S.K., Krishnankutty R., Uddin S., Haris M., Bhat A.A. Therapeutic Effects of Curcumol in Several Diseases; An Overview. Nutr. Cancer. 2021;73:181\u2013195. doi: 10.1080/01635581.2020.1749676.", "ArticleIdList": ["10.1080/01635581.2020.1749676", "32285707"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "8"}, {"Year": "2022", "Month": "4", "Day": "7"}, {"Year": "2022", "Month": "4", "Day": "11"}, {"Year": "2022", "Month": "4", "Day": "23", "Hour": "1", "Minute": "16"}, {"Year": "2022", "Month": "4", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35458763", "PMC9027183", "10.3390/molecules27082568", "molecules27082568"]}}], "PubmedBookArticle": []}